Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Inflamm Bowel Dis

Retrieve available abstracts of 907 articles:
HTML format



Single Articles


    May 2020
  1. MINTZ MJ, Ananthakrishnan AN
    Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis.
    Inflamm Bowel Dis. 2020 May 20. pii: 5840920. doi: 10.1093.
    PubMed     Abstract available


  2. DRAGONI G, De Hertogh G, Vermeire S
    The Role of Citrullination in Inflammatory Bowel Disease: A Neglected Player in Triggering Inflammation and Fibrosis?
    Inflamm Bowel Dis. 2020 May 19. pii: 5840491. doi: 10.1093.
    PubMed     Abstract available


  3. YU A, Friedman S, Ananthakrishnan AN
    Characteristics and Long-Term Outcomes of Pregnancy-Onset Inflammatory Bowel Disease: A Case-Control Study.
    Inflamm Bowel Dis. 2020 May 19. pii: 5840482. doi: 10.1093.
    PubMed     Abstract available


  4. EGBERG MD, Phillips M, Galanko JA, Kappelman M, et al
    Total Abdominal Colectomies With Proctectomy Are Associated With Higher 30-Day Readmission Rates in Children With Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 May 19. pii: 5840483. doi: 10.1093.
    PubMed     Abstract available


  5. RYBINSKI F, Weisser M, Niess JH, Hruz P, et al
    Amoebic Liver Abscess in Crohn Disease Treated With Ustekinumab.
    Inflamm Bowel Dis. 2020 May 14. pii: 5836916. doi: 10.1093.
    PubMed    


  6. BARNES EL, Bauer CM, Sandler RS, Kappelman MD, et al
    Black and White Patients With Inflammatory Bowel Disease Show Similar Biologic Use Patterns With Medicaid Insurance.
    Inflamm Bowel Dis. 2020 May 14. pii: 5836912. doi: 10.1093.
    PubMed     Abstract available


  7. ROSEN MH, Axelrad J, Hudesman D, Rubin DT, et al
    Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
    Inflamm Bowel Dis. 2020 May 12. pii: 5836016. doi: 10.1093.
    PubMed     Abstract available


  8. KERUR B, Benchimol EI, Fiedler K, Stahl M, et al
    Natural History of Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2020 May 9. pii: 5835042. doi: 10.1093.
    PubMed     Abstract available


  9. CORRIDONI D, Chapman T, Antanaviciute A, Satsangi J, et al
    Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies.
    Inflamm Bowel Dis. 2020 May 9. pii: 5834990. doi: 10.1093.
    PubMed     Abstract available


  10. GUZMAN-PRADO Y, Samson O, Segal JP, Limdi JK, et al
    Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 May 9. pii: 5834989. doi: 10.1093.
    PubMed     Abstract available


  11. TURSI A, Vetrone LM, Papa A
    Anti-TNF-alpha Agents in Inflammatory Bowel Disease and Course of COVID-19.
    Inflamm Bowel Dis. 2020 May 8. pii: 5831990. doi: 10.1093.
    PubMed    


  12. VAN GENNEP S, Evers SW, Rietdijk ST, Gielen ME, et al
    High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study.
    Inflamm Bowel Dis. 2020 May 7. pii: 5831697. doi: 10.1093.
    PubMed     Abstract available


  13. PARK KT, Ehrlich OG, Allen JI, Meadows P, et al
    Corrigendum to The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Inflamm Bowel Dis. 2020 May 6. pii: 5831199. doi: 10.1093.
    PubMed    


    April 2020
  14. JACOBS J, Clark-Snustad K, Lee S
    Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib.
    Inflamm Bowel Dis. 2020 Apr 28. pii: 5826022. doi: 10.1093.
    PubMed    


  15. FENTON CG, Taman H, Florholmen J, Sorbye SW, et al
    Transcriptional Signatures That Define Ulcerative Colitis in Remission.
    Inflamm Bowel Dis. 2020 Apr 23. pii: 5823961. doi: 10.1093.
    PubMed     Abstract available


  16. LEVHAR N, Ungar B, Kopylov U, Fudim E, et al
    Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 23. pii: 5823959. doi: 10.1093.
    PubMed     Abstract available


  17. YAO J, Jiang X, You JHS
    A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy.
    Inflamm Bowel Dis. 2020 Apr 20. pii: 5822887. doi: 10.1093.
    PubMed     Abstract available


  18. LINHARES M, Ramos D, Pereira F, Azevedo R, et al
    Hidradenitis Suppurativa and Crohn Disease: A Rare Association.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822088. doi: 10.1093.
    PubMed    


  19. DERER S, Brethack AK, Pietsch C, Jendrek ST, et al
    Inflammatory Bowel Disease-associated GP2 Autoantibodies Inhibit Mucosal Immune Response to Adherent-invasive Bacteria.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822108. doi: 10.1093.
    PubMed     Abstract available



  20. Corrigendum to: Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822087. doi: 10.1093.
    PubMed    



  21. DPP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?
    Inflamm Bowel Dis. 2020 Apr 16. pii: 5820737. doi: 10.1093.
    PubMed    


  22. LEE AS, Hubers J, Osman F, Caldera F, et al
    Don't Be Blue: A Case Series Describing Colonoscope Damage After Chromoendoscopy for Surveillance of Dysplasia in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 6. pii: 5816423. doi: 10.1093.
    PubMed    


    March 2020
  23. BERTANI L, Rossari F, Barberio B, Demarzo MG, et al
    Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.
    Inflamm Bowel Dis. 2020 Mar 31. pii: 5813970. doi: 10.1093.
    PubMed     Abstract available


  24. PATEL P, Gao G, Gulotta G, Dalal S, et al
    Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 27. pii: 5812729. doi: 10.1093.
    PubMed     Abstract available


  25. ORFANOUDAKI E, Foteinogiannopoulou K, Theodoraki E, Koutroubakis IE, et al
    Clinical Value of Proactive Infliximab Drug Monitoring in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 24. pii: 5811190. doi: 10.1093.
    PubMed    


  26. MCCURDY JD, Benchimol EI
    Response to Letter, "Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2020 Mar 21. pii: 5810826. doi: 10.1093.
    PubMed    


  27. XIE H, Zeng D, Chen D, Tang W, et al
    Letter to the Editor: Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Mar 20. pii: 5810369. doi: 10.1093.
    PubMed    


  28. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 18. pii: 5809340. doi: 10.1093.
    PubMed     Abstract available


  29. OSTERMAN MT, Scott FI, Fogt FF, Gilroy ED, et al
    Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE).
    Inflamm Bowel Dis. 2020 Mar 14. pii: 5805376. doi: 10.1093.
    PubMed     Abstract available


  30. YVELLEZ OV, Rai V, Sossenheimer PH, Hart J, et al
    Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study.
    Inflamm Bowel Dis. 2020 Mar 10. pii: 5802337. doi: 10.1093.
    PubMed     Abstract available


  31. BODIWALA V, Marshall T, Das KM, Brant SR, et al
    Comparison of Disease Phenotypes and Clinical Characteristics Among South Asian and White Patients with Inflammatory Bowel Disease at a Tertiary Referral Center.
    Inflamm Bowel Dis. 2020 Mar 7. pii: 5799010. doi: 10.1093.
    PubMed     Abstract available


  32. KARMIRIS K
    Racial Differences in Inflammatory Bowel Disease: A Race With Alternating Winners?
    Inflamm Bowel Dis. 2020 Mar 7. pii: 5799011. doi: 10.1093.
    PubMed    


  33. JANGI S, Ruan A, Korzenik J, de Silva P, et al
    South Asian Patients With Inflammatory Bowel Disease in the United States Demonstrate More Fistulizing and Perianal Crohn Phenotype.
    Inflamm Bowel Dis. 2020 Mar 2. pii: 5771121. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  34. LIN E, Katz S
    Acute Pancreatitis in a Patient With Ulcerative Colitis on Vedolizumab.
    Inflamm Bowel Dis. 2020 Feb 26. pii: 5758182. doi: 10.1093.
    PubMed    


  35. DAI C, Cao Q, Jiang M
    Risk of Venous Thromboembolism After Hospital Discharge in Patients with Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2020 Feb 25. pii: 5755895. doi: 10.1093.
    PubMed    


  36. LI H, Tian F
    Toxic Epidermal Necrolysis Because of Various Herpesviruses Infection After Accelerated Infliximab Induction in a Chinese Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Feb 22. pii: 5748143. doi: 10.1093.
    PubMed    


  37. LEY D, Martin B, Caldera F
    Use of an iPhone Application to Increase Adherence in Patients With Ulcerative Colitis in Remission: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2020 Feb 22. pii: 5748139. doi: 10.1093.
    PubMed    


  38. PEVERELLE M, Mills C, Testro A, Gow P, et al
    Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 20. pii: 5741005. doi: 10.1093.
    PubMed    


  39. OKAMOTO D, Kawai Y, Kakuta Y, Naito T, et al
    Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP Array.
    Inflamm Bowel Dis. 2020 Feb 19. pii: 5740361. doi: 10.1093.
    PubMed     Abstract available


  40. HAMDEH S, Aziz M, Altayar O, Olyaee M, et al
    Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 Feb 17. pii: 5739148. doi: 10.1093.
    PubMed     Abstract available


  41. LAW CCY, Koh D, Bao Y, Jairath V, et al
    Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 Feb 12. pii: 5734556. doi: 10.1093.
    PubMed     Abstract available


  42. PIGNICZKI D, Farkas K, Molnar T
    The Theoretical Scenario Experienced in a Real-Life Case of Ulcerative Colitis and Associated Primary Sclerosing Cholangitis: Case 123.
    Inflamm Bowel Dis. 2020 Feb 11. pii: 5733139. doi: 10.1093.
    PubMed    


  43. LEE TW
    Editorial: Risk of Cancer Development in IBD-Inflammation vs Immunosuppression.
    Inflamm Bowel Dis. 2020;26:460-461.
    PubMed    


  44. BERNSTEIN CN
    Is Antibiotic Use a Cause of IBD Worldwide?
    Inflamm Bowel Dis. 2020;26:448-449.
    PubMed    


  45. EL-DALLAL M, Chen Y, Lin Q, Rakowsky S, et al
    Meta-analysis of Virtual-based Chromoendoscopy Compared With Dye-spraying Chromoendoscopy Standard and High-definition White Light Endoscopy in Patients With Inflammatory Bowel Disease at Increased Risk of Colon Cancer.
    Inflamm Bowel Dis. 2020 Feb 8. pii: 5731339. doi: 10.1093.
    PubMed     Abstract available


  46. KORNBLUTH A
    Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?
    Inflamm Bowel Dis. 2020 Feb 7. pii: 5729887. doi: 10.1093.
    PubMed    


  47. CARNEY H, Marrie RA, Bolton JM, Patten SB, et al
    Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 6. pii: 5728525. doi: 10.1093.
    PubMed     Abstract available


  48. PENG Y, Thomas AS, Wei D, Tan D, et al
    An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia.
    Inflamm Bowel Dis. 2020 Feb 4. pii: 5721970. doi: 10.1093.
    PubMed    


  49. JABANDZIEV P, Bohosova J, Pinkasova T, Kunovsky L, et al
    The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 3. pii: 5721205. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  50. MCCURDY JD, Kuenzig ME, Smith G, Spruin S, et al
    Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Jan 29. pii: 5717328. doi: 10.1093.
    PubMed     Abstract available


  51. BAFFORD AC, Cross RK
    Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease Extends beyond Hospitalization.
    Inflamm Bowel Dis. 2020 Jan 29. pii: 5717307. doi: 10.1093.
    PubMed    


  52. SZANTO KJ, Rutka M, Pigniczki D, Farkas K, et al
    Serological Status of Inflammatory Bowel Disease Patients Before Starting Biological Therapy - Data From a Tertiary Centre of the Best Vaccined Country.
    Inflamm Bowel Dis. 2020 Jan 24. pii: 5715025. doi: 10.1093.
    PubMed    


  53. MARTINELLI M, Miele E
    Implementation and Widespread of Inflammatory Bowel Disease Vaccination and Immunization Guidelines: Not an Easy Task.
    Inflamm Bowel Dis. 2020 Jan 24. pii: 5715024. doi: 10.1093.
    PubMed    


  54. LEE AA, Rao K, Limsrivilai J, Gillilland M, et al
    Temporal Gut Microbial Changes Predict Recurrent Clostridiodes Difficile Infection in Patients With and Without Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jan 23. pii: 5714595. doi: 10.1093.
    PubMed     Abstract available


  55. COLLINS SM
    Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714219. doi: 10.1093.
    PubMed     Abstract available


  56. HOU G, Bishu S
    Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714220. doi: 10.1093.
    PubMed    


  57. CONRAD MA, Kelsen JR
    Editorial to Temporal Gut Microbial Changes Predict Recurrent Clostridium difficile Infection in Patients With and Without Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714218. doi: 10.1093.
    PubMed    


  58. GUPTA N, Liu C, King E, Sylvester F, et al
    Continued Statural Growth in Older Adolescents and Young Adults With Crohn's Disease and Ulcerative Colitis Beyond the Time of Expected Growth Plate Closure.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714217. doi: 10.1093.
    PubMed     Abstract available


  59. PRATHAPAN KM, Ramos Rivers C, Anderson A, Koutroumpakis F, et al
    Peripheral Blood Eosinophilia and Long-term Severity in Pediatric-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 21. pii: 5711281. doi: 10.1093.
    PubMed     Abstract available


  60. GUBATAN J, Mehigan GA, Villegas F, Mitsuhashi S, et al
    Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells.
    Inflamm Bowel Dis. 2020 Jan 18. pii: 5709590. doi: 10.1093.
    PubMed     Abstract available


  61. DIN H, Anderson AJ, Ramos Rivers C, Proksell S, et al
    Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707489. doi: 10.1093.
    PubMed     Abstract available


  62. MARTINELLI M, Miele E
    Evaluation of EBV Status and Thiopurine Use in Pediatric Inflammatory Bowel Disease: Time to be a Standard of Care.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707490. doi: 10.1093.
    PubMed    


  63. EL-MATARY W
    Routine Testing for EBV Status in Children With Inflammatory Bowel Disease: Are We Overreacting?
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707482. doi: 10.1093.
    PubMed    


  64. KATINIOS G, Casado-Bedmar M, Walter SA, Vicario M, et al
    Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707481. doi: 10.1093.
    PubMed     Abstract available


  65. PEVERELLE M, Paleri S, Hughes J, De Cruz P, et al
    Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707461. doi: 10.1093.
    PubMed     Abstract available


  66. WONG U, Cross RK
    Are Inflammatory Bowel Disease Patients With Diabetes Mellitus at Increased Risk for Poor Outcomes Including Greater Health Care Utilization?
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707487. doi: 10.1093.
    PubMed    


  67. PERRY C, Kapur N, Barrett TA
    DDP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?
    Inflamm Bowel Dis. 2020 Jan 8. pii: 5698302. doi: 10.1093.
    PubMed    


  68. PINTO-LOPES P, Afonso J, Pinto-Lopes R, Rocha C, et al
    Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 8. pii: 5698249. doi: 10.1093.
    PubMed     Abstract available


  69. ROOSENBOOM B, van Lochem EG, Smids C, Groenen MJM, et al
    Analysis of Intestinal T-Cell Subsets in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020;26:e13.
    PubMed    


  70. BAUER CM, Younis A, Herfarth H, Barnes EL, et al
    Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e5.
    PubMed    


  71. CASANOVA MJ, Chaparro M, Gisbert JP
    Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease".
    Inflamm Bowel Dis. 2020;26:e6.
    PubMed    


  72. BARNES EL
    Opportunistic Infections and Opportunities for Action.
    Inflamm Bowel Dis. 2020;26:301-303.
    PubMed    


  73. ANNESE V
    TDM of Anti-TNF Agents: The Importance of Being Active!
    Inflamm Bowel Dis. 2020;26:271-272.
    PubMed    


  74. MORAES L, Magnusson MK, Mavroudis G, Polster A, et al
    Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms.
    Inflamm Bowel Dis. 2020 Jan 4. pii: 5696669. doi: 10.1093.
    PubMed     Abstract available


  75. YU A, Friedman S, Ananthakrishnan AN
    Incidence and Predictors of Flares in the Postpartum Year Among Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 2. pii: 5694104. doi: 10.1093.
    PubMed     Abstract available


  76. KUROWSKI JA, Achkar JP
    Underutilization of Combination Anti-TNF Therapy in Population-based Study.
    Inflamm Bowel Dis. 2020;26:158-159.
    PubMed    


  77. DE FELICE KM
    Patients Perception of Risks and Benefits of Biologic Therapy.
    Inflamm Bowel Dis. 2020;26:147-149.
    PubMed     Abstract available


  78. FRANCO DL, Click B
    Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: Is the Juice Worth the Squeeze?
    Inflamm Bowel Dis. 2020;26:112-113.
    PubMed    


    December 2019
  79. DAI C, Jiang M, Sun MJ
    Disease Duration and the Risk of Treatment Failure in Biologic-Treated Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 30. pii: 5690100. doi: 10.1093.
    PubMed    


  80. KEVANS D, Kirsch R, Dargavel C, Kabakchiev B, et al
    Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 28. pii: 5688912. doi: 10.1093.
    PubMed     Abstract available


  81. ESCUDERO-HERNANDEZ C, Montalvillo E, Antolin B, Bernardo D, et al
    Different Intraepithelial CD3+ Cell Numbers in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 28. pii: 5688873. doi: 10.1093.
    PubMed    


  82. FAYE AS, Oh A, Kumble LD, Kiran RP, et al
    Fertility Impact of Initial Operation Type for Female Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2019 Dec 27. pii: 5688242. doi: 10.1093.
    PubMed     Abstract available


  83. KUENZIG ME, Hawken S, Wilson K, Talarico R, et al
    Serum Newborn Screening Blood Metabolites Are not Associated With Childhood-onset Inflammatory Bowel Disease: A Population-based Matched Case-control Study.
    Inflamm Bowel Dis. 2019 Dec 12. pii: 5674034. doi: 10.1093.
    PubMed     Abstract available


  84. CHEN LA
    Intestinal Microbiota Transplantation for Patients With Inflammatory Bowel Disease Prevents Recurrence of C. difficile Infections but Not Recurrence of Gastrointestinal Symptoms.
    Inflamm Bowel Dis. 2019 Dec 10. pii: 5673070. doi: 10.1093.
    PubMed    


  85. TARIQ R, Disbrow MB, Dibaise JK, Orenstein R, et al
    Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 9. pii: 5673067. doi: 10.1093.
    PubMed     Abstract available


  86. POUILLON L, Hoefkens E, Verheyen V, Bronswijk M, et al
    Letter to the Editor: Feasibility and Efficiency of an E-Health Preadmission Assessment System for Intravenous Therapy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650900. doi: 10.1093.
    PubMed    


  87. YANG B, Liu X, Mei Q
    HMGB1-Positive Platelet Microparticles May Be a Biomarker of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650909. doi: 10.1093.
    PubMed    



  88. Corrigendum to A Diagnosis of Inflammatory Bowel Disease and Access to Psychotherapy: Rural Patients Who Accept Treatment Report Psychosomatic Benefits.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650796. doi: 10.1093.
    PubMed    


  89. OUAHED J, Spencer E, Kotlarz D, Shouval DS, et al
    Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5675340. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  90. CHENG J, Shen H, Chowdhury R, Abdi T, et al
    Potential of Electrical Neuromodulation for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 29. pii: 5648005. doi: 10.1093.
    PubMed     Abstract available


  91. JODELEIT H, Caesar J, Villarroel Aguilera C, Sterz S, et al
    The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rgamma null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for
    Inflamm Bowel Dis. 2019 Nov 29. pii: 5648003. doi: 10.1093.
    PubMed     Abstract available


  92. CHATEAU T, Peyrin-Biroulet L
    Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks.
    Inflamm Bowel Dis. 2019 Nov 26. pii: 5643743. doi: 10.1093.
    PubMed    


  93. CHANDRAKUMAR A, Zohni H, El-Matary W
    Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 25. pii: 5643019. doi: 10.1093.
    PubMed     Abstract available


  94. BASSON AR, Gomez-Nguyen A, Menghini P, Butto LF, et al
    Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Nov 21. pii: 5637456. doi: 10.1093.
    PubMed     Abstract available


  95. NGUYEN NH, Kurnool S, Dulai PS, Boland BS, et al
    Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Nov 21. pii: 5636894. doi: 10.1093.
    PubMed     Abstract available


  96. MARCIL V, Levy E, Amre D, Bitton A, et al
    Erratum: A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?
    Inflamm Bowel Dis. 2019 Nov 20. pii: 5634260. doi: 10.1093.
    PubMed    


  97. THAKUR ER, Sansgiry S, Kramer JR, Waljee AK, et al
    The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 15. pii: 5625871. doi: 10.1093.
    PubMed     Abstract available


  98. HANSEN TM, Sabourin BC, Oketola B, Bernstein CN, et al
    Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
    Inflamm Bowel Dis. 2019 Nov 14. pii: 5625670. doi: 10.1093.
    PubMed     Abstract available


  99. SHMIDT E, Saha S, Sands BE
    Reply to Letter to the Editor of Dr. Lai and Colleagues.
    Inflamm Bowel Dis. 2019;25:e166.
    PubMed    


  100. FAYE AS, Hung KW, Cheng K, Blackett JW, et al
    Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613524. doi: 10.1093.
    PubMed     Abstract available


  101. MARTINELLI M, Giugliano FP, Strisciuglio C, Urbonas V, et al
    Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613525. doi: 10.1093.
    PubMed     Abstract available


  102. LOPETUSO LR, Gasbarrini A
    Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613523. doi: 10.1093.
    PubMed    


  103. VADSTRUP K, Alulis S, Borsi A, Gustafsson N, et al
    Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015.
    Inflamm Bowel Dis. 2019 Nov 4. pii: 5613986. doi: 10.1093.
    PubMed     Abstract available


  104. DE JONG ME, Gillis VELM, Derikx LAAP, Hoentjen F, et al
    No Increased Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease and Postinflammatory Polyps.
    Inflamm Bowel Dis. 2019 Nov 2. pii: 5611176. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  105. SHAH NB, Haydek J, Slaughter J, Ashton JR, et al
    Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610710. doi: 10.1093.
    PubMed     Abstract available


  106. CLICK B, Lopez R, Arrigain S, Schold J, et al
    Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610752. doi: 10.1093.
    PubMed     Abstract available


  107. TRUTA B, Leeds IL, Canner JK, Efron JE, et al
    Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610578. doi: 10.1093.
    PubMed     Abstract available


  108. GU P, Feagins LA
    Dining With Inflammatory Bowel Disease: A Review of the Literature on Diet in the Pathogenesis and Management of IBD.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610412. doi: 10.1093.
    PubMed     Abstract available


  109. AL DRAIWEESH S, Ma C, Alkhattabi M, McDonald C, et al
    Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 28. pii: 5608313. doi: 10.1093.
    PubMed     Abstract available


  110. MCCOMBIE A, Walmsley R, Barclay M, Ho C, et al
    A Noninferiority Randomized Clinical Trial of the Use of the Smartphone-Based Health Applications IBDsmart and IBDoc in the Care of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Oct 23. pii: 5603780. doi: 10.1093.
    PubMed     Abstract available


  111. CALVET X, Saldana R, Carpio D, Minguez M, et al
    Improving Quality of Care in Inflammatory Bowel Disease Through Patients' Eyes: IQCARO Project.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5571234. doi: 10.1093.
    PubMed     Abstract available


  112. BARNES EL, Jiang Y, Kappelman MD, Long MD, et al
    Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5601649. doi: 10.1093.
    PubMed     Abstract available


  113. HAAC BE, Nemirovsky A, Teeter W, Geyer A, et al
    Injury Characteristics and Outcomes of Patients With Inflammatory Bowel Disease After Trauma: A Propensity Score Matched Analysis.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5601417. doi: 10.1093.
    PubMed     Abstract available


  114. GROSSI V, Hyams JS, Glidden NC, Knight BE, et al
    Characterizing Clinical Features and Creating a Gene Expression Profile Associated With Pain Burden in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5599699. doi: 10.1093.
    PubMed     Abstract available


  115. KRISTENSEN MS, Kjaerulff TM, Ersboll AK, Green A, et al
    Erratum: The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Inflamm Bowel Dis. 2019;25:e152.
    PubMed    


  116. WANG MH, Mousa OY, Friton JJ, Raffals LE, et al
    Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5593848. doi: 10.1093.
    PubMed     Abstract available


  117. VAN DER HAVE M, Oldenburg B
    Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition?
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5598454. doi: 10.1093.
    PubMed    


  118. SINGH A, Koenen B, Kirby DF
    Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5598917. doi: 10.1093.
    PubMed     Abstract available


  119. KANE S
    Contraception and Antibiotics.
    Inflamm Bowel Dis. 2019;25:e148.
    PubMed    


  120. MIRJALALI H, Shahrokh S, Asadzadeh Aghdaei H, Zali MR, et al
    Letter to the Editor: Activated Toxoplasma May Attenuate the Effect of Azathioprine and Deteriorate the Symptoms in IBD Patients via mTORC1 Manipulation.
    Inflamm Bowel Dis. 2019;25:e137.
    PubMed    


  121. EISENSTEIN S, Holubar SD, Hilbert N, Bordeianou L, et al
    The ACS National Surgical Quality Improvement Program-Inflammatory Bowel Disease Collaborative: Design, Implementation, and Validation of a Disease-specific Module.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589173. doi: 10.1093.
    PubMed     Abstract available


  122. LAI SW, Kuo YH, Fang CW, Liao KF, et al
    Inflammatory Bowel Disease and the Risk of Erectile Dysfunction.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589171. doi: 10.1093.
    PubMed    


  123. WATT P
    Recommendations for the Provision of Psychological Support in a Rural Inflammatory Bowel Disease Clinic.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589169. doi: 10.1093.
    PubMed    


  124. NETO MBB, Gregory MH, Ramos GP, Bazerbachi F, et al
    Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 15. pii: 5588067. doi: 10.1093.
    PubMed     Abstract available


  125. KAFIL TS, Nguyen TM, MacDonald JK, Chande N, et al
    Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
    Inflamm Bowel Dis. 2019 Oct 15. pii: 5588062. doi: 10.1093.
    PubMed     Abstract available


  126. LAI SW, Kuo YH, Liao KF
    Cancer Risk in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 14. pii: 5587055. doi: 10.1093.
    PubMed    


  127. SCHOFIELD JB, Haboubi N
    Histopathological Mimics of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 10. pii: 5584939. doi: 10.1093.
    PubMed     Abstract available


  128. KRISHNA M, Salako A, Fofanova T, Kellermayer R, et al
    Parental Education May Differentially Impact Pediatric Inflammatory Bowel Disease Phenotype Risk.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581966. doi: 10.1093.
    PubMed     Abstract available


  129. DAY AS
    Re: Parental Education May Differentially Modulate Pediatric Inflammatory Bowel Disease Phenotype Risk.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581964. doi: 10.1093.
    PubMed    


  130. NARDONE OM, Shivaji UN, Ferruzza V, Ghosh S, et al
    Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581902. doi: 10.1093.
    PubMed     Abstract available


  131. KAYAL M, Plietz M, Rizvi A, Radcliffe M, et al
    Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581903. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  132. DANILUK U, Daniluk J, Ciborowski M
    Reply to Letter to the Editor of Dr. Sitkin et al., Regarding "Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome is Another Key to the Pathogenesis of Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574842. doi: 10.1093.
    PubMed    


  133. SITKIN S, Demyanova E, Vakhitov T, Pokrotnieks J, et al
    Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574840. doi: 10.1093.
    PubMed    


  134. CHANDE N, Costello SP, Limketkai BN, Parker CE, et al
    Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574841. doi: 10.1093.
    PubMed    


  135. MOSER T, Bubel NE, Machegger L, Pikija S, et al
    Cerebral Vasculitis in Crohn's Disease: Always a Complication of Inflammatory Bowel Disease or Tumor Necrosis Factor-Alpha Inhibition?
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574838. doi: 10.1093.
    PubMed    


  136. KELSEN JR, Conrad MA, Dawany N, Patel T, et al
    The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5575070. doi: 10.1093.
    PubMed     Abstract available


  137. GIRON F, Pasto A, Tasciotti E, Abraham BP, et al
    Nanotechnology in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574918. doi: 10.1093.
    PubMed     Abstract available


  138. LONG MD, Smith TW, Dibonaventura M, Gruben D, et al
    Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574848. doi: 10.1093.
    PubMed     Abstract available


  139. ABU-SBEIH H, Wang Y
    Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574910. doi: 10.1093.
    PubMed     Abstract available


  140. NGUYEN GC, Low D, Chong RY, Diong C, et al
    Utilization of Diagnostic Imaging and Ionization Radiation Exposure Among an Inflammatory Bowel Disease Inception Cohort.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574895. doi: 10.1093.
    PubMed     Abstract available


  141. CHIBA M, Nakane K, Abe H, Komatsu M, et al
    Onset of Ulcerative Colitis in a Patient with Nonalcoholic Fatty Liver Disease (NAFLD): Dramatic Effect of Plant-based Diet for NAFLD.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574851. doi: 10.1093.
    PubMed     Abstract available


  142. CLARKE WT, Papamichael K, Casteele NV, Germansky KA, et al
    Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574728. doi: 10.1093.
    PubMed    


  143. VAN DE VEN SEM, Derikx LAAP, Nagtegaal ID, van Herpen CM, et al
    Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574717. doi: 10.1093.
    PubMed     Abstract available


  144. BOLAND K, Greener T, Kabakchiev B, Stempak J, et al
    Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing.
    Inflamm Bowel Dis. 2019 Sep 17. pii: 5570706. doi: 10.1093.
    PubMed     Abstract available


  145. ZHUANG X, Li T, Li M, Huang S, et al
    Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 9. pii: 5566405. doi: 10.1093.
    PubMed     Abstract available


  146. LUTHER J, Dave M
    Rising Inflammatory Bowel Disease Prevalence Highlights the Need for Effective, Cost-Effective Therapies.
    Inflamm Bowel Dis. 2019 Sep 7. pii: 5565004. doi: 10.1093.
    PubMed    


    August 2019
  147. LIN Z, Wu H, Fu Y, Dai S, et al
    Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy.
    Inflamm Bowel Dis. 2019 Aug 31. pii: 5557802. doi: 10.1093.
    PubMed     Abstract available


  148. GEORGE J, Singh S, Dulai PS, Ma C, et al
    Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2019 Aug 30. pii: 5556866. doi: 10.1093.
    PubMed     Abstract available


  149. CASANOVA MJ, Chaparro M, Minguez M, Ricart E, et al
    Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
    Inflamm Bowel Dis. 2019 Aug 29. pii: 5556445. doi: 10.1093.
    PubMed     Abstract available


  150. KOKLU S, Koklu H
    Rectal Candidiasis Mimicking Ulcerative Colitis in an Immunocompetent Patient.
    Inflamm Bowel Dis. 2019 Aug 29. pii: 5556472. doi: 10.1093.
    PubMed    


  151. BARBERIO B, D'Inca R, Facchin S, Dalla Gasperina M, et al
    Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab.
    Inflamm Bowel Dis. 2019 Aug 29. pii: 5556462. doi: 10.1093.
    PubMed     Abstract available


  152. GREGORY MH, Ciorba MA, Wiitala WL, Stidham RW, et al
    The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Aug 27. pii: 5555523. doi: 10.1093.
    PubMed     Abstract available


  153. ROSEIRA J, Magro F, Fernandes S, Simoes C, et al
    Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study.
    Inflamm Bowel Dis. 2019 Aug 27. pii: 5555468. doi: 10.1093.
    PubMed     Abstract available


  154. QIN X
    Impaired Inactivation of Digestive Proteases in Lower Gut Due to Inhibition of Gut Bacteria by Food Additives Such as Saccharin and Sucralose as Main Cause of Inflammatory Bowel Disease: A Two-Decades-Long Hypothesis Warrants Testing.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554159. doi: 10.1093.
    PubMed    


  155. CALDERA F, Hillman L, Saha S, Wald A, et al
    Immunogenicity of High Dose Influenza Vaccine for Patients with Inflammatory Bowel Disease on Anti-TNF Monotherapy: A Randomized Clinical Trial.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554370. doi: 10.1093.
    PubMed     Abstract available


  156. EROS A, Soos A, Hegyi P, Szakacs Z, et al
    Spotlight on Transition in Patients With Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554155. doi: 10.1093.
    PubMed     Abstract available


  157. KAIMAKLIOTIS P, Ramadugu A, Kang J, Trivedi I, et al
    Comment on: "Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol".
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554376. doi: 10.1093.
    PubMed    


  158. YE Y, Manne S, Treem WR, Bennett D, et al
    Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554163. doi: 10.1093.
    PubMed     Abstract available


  159. FONDELL AW, Mosha MH, Frank CR, Brangi JM, et al
    Health Care Cost for Children Newly Diagnosed With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554164. doi: 10.1093.
    PubMed     Abstract available


  160. KHALILI H
    The Changing Epidemiology of Inflammatory Bowel Disease: What Goes Up May Come Down.
    Inflamm Bowel Dis. 2019 Aug 23. pii: 5554124. doi: 10.1093.
    PubMed     Abstract available


  161. TORABI M, Bernstein CN, Yu BN, Wickramasinghe L, et al
    Geographical Variation and Factors Associated With Inflammatory Bowel Disease in a Central Canadian Province.
    Inflamm Bowel Dis. 2019 Aug 23. pii: 5554123. doi: 10.1093.
    PubMed     Abstract available


  162. DEBRUYN J
    Response to the Letter by Dr. Freddy Calder.
    Inflamm Bowel Dis. 2019;25:e104.
    PubMed    


  163. BHATTACHARYA S, Cross RK
    Is Endoscopic Remission in Ulcerative Colitis Still Good Enough?
    Inflamm Bowel Dis. 2019 Aug 14. pii: 5550113. doi: 10.1093.
    PubMed    


  164. LAI SW, Kuo YH, Liao KF
    Increased Risk of Parkinson Disease in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Aug 13. pii: 5548979. doi: 10.1093.
    PubMed    


  165. WEIMERS P, Halfvarson J, Saunders-Pullman R, Ludvigsson JF, et al
    Inflammatory Bowel Disease and Parkinson's Disease: A Reply to Letter to the Editor of Shih-Wei Lai.
    Inflamm Bowel Dis. 2019 Aug 13. pii: 5548981. doi: 10.1093.
    PubMed    


  166. LEGA S, Pin A, Arrigo S, Cifaldi C, et al
    Diagnostic Approach to Monogenic Inflammatory Bowel Disease in Clinical Practice: A Ten-Year Multicentric Experience.
    Inflamm Bowel Dis. 2019 Aug 3. pii: 5543289. doi: 10.1093.
    PubMed     Abstract available


  167. DREESEN E, Kantasiripitak W, Detrez I, Stefanovic S, et al
    A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542810. doi: 10.1093.
    PubMed     Abstract available


  168. LISKA D, Bora Cengiz T, Novello M, Aiello A, et al
    Do Patients With Inflammatory Bowel Disease Benefit from an Enhanced Recovery Pathway?
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542814. doi: 10.1093.
    PubMed     Abstract available


  169. KAYAL M, Radcliffe M, Plietz M, Rosman A, et al
    Portomesenteric Venous Thrombosis in Patients Undergoing Surgery for Medically Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542812. doi: 10.1093.
    PubMed     Abstract available


  170. LIGHTNER AL
    Should Surgical Inflammatory Bowel Disease Patients Be Given Extended Venous Thromboembolic Prophylaxis Postoperatively?
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542811. doi: 10.1093.
    PubMed    


    July 2019
  171. NIKLINSKA-SCHIRTZ BJ, Kugathasan S
    Anti-TNF Therapy Is Emerging as the Primary Treatment Modality in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jul 19. pii: 5536295. doi: 10.1093.
    PubMed    


  172. EL-MATARY W, Leung S, Tennakoon A, Benchimol EI, et al
    Trends of Utilization of Tumor Necrosis Factor Antagonists in Children With Inflammatory Bowel Disease: A Canadian Population-Based Study.
    Inflamm Bowel Dis. 2019 Jul 19. pii: 5536313. doi: 10.1093.
    PubMed     Abstract available


  173. BIANCONE L, Armuzzi A, Scribano ML, Castiglione F, et al
    Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Inflamm Bowel Dis. 2019 Jul 19. pii: 5536256. doi: 10.1093.
    PubMed     Abstract available


  174. WATT P, Abbass A
    A Comparative Case Study of the Impact of Psychotherapy on Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Jul 18. pii: 5531848. doi: 10.1093.
    PubMed    


  175. SHERIFF MZ, Mansoor E, Luther J, Ananthakrishnan AN, et al
    Opportunistic Infections Are More Prevalent in Crohn's Disease and Ulcerative Colitis: A Large Population-Based Study.
    Inflamm Bowel Dis. 2019 Jul 17. pii: 5533446. doi: 10.1093.
    PubMed     Abstract available


  176. BORUM ML, Taneja SL, Corinaldi M
    Health Literacy Assessments May Be Inconsistently Conducted in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e94.
    PubMed    


  177. SAROLI PALUMBO C, Bessissow T, Sebastiani G
    Reply to "Transient Elastography in IBD Patients".
    Inflamm Bowel Dis. 2019;25:e95.
    PubMed    


  178. VAN EVERDINGEN CK, Meijer B, Gearry RB
    Transient Elastography in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e96.
    PubMed    


  179. GOYAL A, Morowitz M
    Author's Reply to Drs. Franco Scaldaferri and Valentina Petito, PhD.
    Inflamm Bowel Dis. 2019;25:e102.
    PubMed    


  180. KOCHAR B, Long MD, Herfarth HH
    Antidepressants in IBD: Healthy Adherer Effect?
    Inflamm Bowel Dis. 2019;25:e98.
    PubMed    


  181. NARULA N, Pinto-Sanchez MI, Calo NC, Ford AC, et al
    Response to Letter by Moulton et al.
    Inflamm Bowel Dis. 2019;25:e99.
    PubMed    


  182. VELEGRAKI M, Flamourakis M, Kazamias G, Georgiou G, et al
    Replacement Resistant Iron Deficiency Anemia in a Patient With Ulcerative Colitis in Remission: Investigating Beyond the Obvious.
    Inflamm Bowel Dis. 2019 Jul 13. pii: 5532048. doi: 10.1093.
    PubMed    



  183. Corrigendum to Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Inflamm Bowel Dis. 2019 Jul 13. pii: 5532047. doi: 10.1093.
    PubMed    


  184. MANTAKA A, Orfanoudaki E, Koutroubakis IE
    Letter to the Editor: Is There a Role for Switching Infliximab in Order to Regain Anti-TNF Response in Cases With Active Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2019 Jul 13. pii: 5531850. doi: 10.1093.
    PubMed    


  185. YAO D, Dong M, Dai C, Wu S, et al
    Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer.
    Inflamm Bowel Dis. 2019 Jul 9. pii: 5530266. doi: 10.1093.
    PubMed     Abstract available


  186. BAUMAN LE, Xiong Y, Mizuno T, Minar P, et al
    Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jul 9. pii: 5530269. doi: 10.1093.
    PubMed     Abstract available


  187. TROELSEN FS, Jick S
    Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink.
    Inflamm Bowel Dis. 2019 Jul 2. pii: 5527229. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  188. POYATO-BORREGO M, Segura-Sampedro JJ, Martin-Gonzalez J, Torres-Dominguez Y, et al
    High Prevalence of Apical Periodontitis in Patients With Inflammatory Bowel Disease: An Age- and Gender- matched Case-control Study.
    Inflamm Bowel Dis. 2019 Jun 27. pii: 5524347. doi: 10.1093.
    PubMed     Abstract available


  189. BARTA Z
    Apical Periodontitis in Patients With Inflammatory Bowel Disease: A Puppet Master?
    Inflamm Bowel Dis. 2019 Jun 27. pii: 5524346. doi: 10.1093.
    PubMed     Abstract available


  190. LIAO KF, Lai SW
    Increased Incidence of Herpes Zoster Infection in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jun 27. pii: 5524337. doi: 10.1093.
    PubMed    


  191. FERNANDES SR, Bernardo S, Simoes C, Goncalves AR, et al
    Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jun 27. pii: 5524344. doi: 10.1093.
    PubMed     Abstract available


  192. MENCHINI CB
    Pediatric Inflammatory Bowel Disease Complications Are More Likely on the Weekend.
    Inflamm Bowel Dis. 2019 Jun 27. pii: 5524339. doi: 10.1093.
    PubMed    


  193. TARGOWNIK LE, Benchimol EI, Witt J, Bernstein CN, et al
    The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jun 18. pii: 5520231. doi: 10.1093.
    PubMed     Abstract available


  194. FERRER-PICON E, Dotti I, Corraliza AM, Mayorgas A, et al
    Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jun 18. pii: 5520228. doi: 10.1093.
    PubMed     Abstract available


  195. EL-MATARY W, Kuenzig ME, Singh H, Okoli G, et al
    Disease-Associated Costs in Children With Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2019 Jun 18. pii: 5520192. doi: 10.1093.
    PubMed     Abstract available


  196. ZHAO S, Xie Q, Zhao Z
    Reply to Comment on "Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis" by Li Y and Liu X.
    Inflamm Bowel Dis. 2019;25:e78-e81.
    PubMed    


  197. GIANNINI EG, Demarzo MG, Bodini G
    Reproducibility and Transportability of the Absence of Incremental Infectious Adverse Events in Patients With Higher Anti-TNF Drug Levels.
    Inflamm Bowel Dis. 2019;25:e73.
    PubMed    


  198. KRUGER AJ, Hinton A, Afzali A
    To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2019;25:e74-e76.
    PubMed    


  199. KURIN M, Katz J, Kodish E, Lashner B, et al
    Informed Consent in IBD Trials: Where We Are and Where We Need to Go.
    Inflamm Bowel Dis. 2019;25:1115-1119.
    PubMed     Abstract available


  200. GROSSBERG LB
    A Case Report of Successful Treatment of Crohn's Disease and Psoriasis With Guselkumab.
    Inflamm Bowel Dis. 2019;25:e84.
    PubMed    


  201. GARCIA GARCIA MJ, Rivero Tirado M, Callizo MEP
    Paradoxical Arthritis in Inflammatory Bowel Diasease Patients on Ustekinumab Treatment.
    Inflamm Bowel Dis. 2019;25:e89.
    PubMed    


  202. SIMONS-LINARES CR, Chahal P
    Successful EUS-guided Drainage of a Persistent Subdiaphragmatic Fluid Collection in a Patient With Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:e85-e86.
    PubMed    


  203. LIGHTNER AL, Alsughayer A, Wang Z, McKenna NP, et al
    Short- and Long-term Outcomes After Ileal Pouch Anal Anastomosis in Pediatric Patients: A Systematic Review.
    Inflamm Bowel Dis. 2019;25:1152-1168.
    PubMed     Abstract available


  204. KRISHNAKUMAR C, Ballengee CR, Liu C, Kim MO, et al
    Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study.
    Inflamm Bowel Dis. 2019;25:1208-1217.
    PubMed     Abstract available


  205. ZHAO M, Lo BZS, Vester-Andersen MK, Vind I, et al
    A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort.
    Inflamm Bowel Dis. 2019;25:1227-1236.
    PubMed     Abstract available


  206. EVERHOV AH, Khalili H, Askling J, Myrelid P, et al
    Work Loss Before and After Diagnosis of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:1237-1247.
    PubMed     Abstract available


  207. JIN L, Li L, Hu C, Paez-Cortez J, et al
    Integrative Analysis of Transcriptomic and Proteomic Profiling in Inflammatory Bowel Disease Colon Biopsies.
    Inflamm Bowel Dis. 2019 Jun 7. pii: 5512545. doi: 10.1093.
    PubMed     Abstract available


  208. DALEY SK, Witte MH, Washington J, Bernas M, et al
    Role of Lymphatic Deficiency in the Pathogenesis and Progression of Inflammatory Bowel Disease to Colorectal Cancer in an Experimental Mouse Model.
    Inflamm Bowel Dis. 2019 Jun 7. pii: 5512544. doi: 10.1093.
    PubMed     Abstract available


  209. CALDERA F, Farraye FA, Rosh JR, Hayney MS, et al
    Prudence Using Serology to Determine Vaccine-Induced Immunity to Measles and Varicella in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jun 5. pii: 5511553. doi: 10.1093.
    PubMed    


    May 2019
  210. JULSGAARD M, Hvas CL, Gearry RB, Gibson PR, et al
    Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.
    Inflamm Bowel Dis. 2019 May 29. pii: 5506434. doi: 10.1093.
    PubMed     Abstract available


  211. MEI Y, Ye S, Han W, Yang Q, et al
    Clinical Significance of Potassium Channel and NLRP3 Expression in Platelets of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 May 29. pii: 5505410. doi: 10.1093.
    PubMed    


  212. MAGG T, Shcherbina A, Arslan D, Desai MM, et al
    CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 May 22. pii: 5496841. doi: 10.1093.
    PubMed     Abstract available


  213. LONG MD
    A Novel Index to Measure Patient-Reported Outcomes in Clinical Practice and Research: The Inflammatory Bowel Disease Symptom Inventory-Ready for Prime Time?
    Inflamm Bowel Dis. 2019 May 22. pii: 5497447. doi: 10.1093.
    PubMed    


  214. TOKARZ R, Hyams JS, Mack DR, Boyle B, et al
    Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 May 21. pii: 5493583. doi: 10.1093.
    PubMed     Abstract available


  215. PARK KT, Ehrlich OG, Allen JI, Meadows P, et al
    The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Inflamm Bowel Dis. 2019 May 21. pii: 5490919. doi: 10.1093.
    PubMed     Abstract available


  216. KEYASHIAN K, Dehghan M, Sceats L, Kin C, et al
    Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States.
    Inflamm Bowel Dis. 2019 May 16. pii: 5490623. doi: 10.1093.
    PubMed     Abstract available


  217. HORTA D, Lira A, Sanchez-Lloansi M, Villoria A, et al
    A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 May 15. pii: 5489814. doi: 10.1093.
    PubMed     Abstract available


  218. ALLEY K, Singla A, Afzali A
    Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 May 14. pii: 5489158. doi: 10.1093.
    PubMed     Abstract available


  219. LEBER A, Hontecillas R, Zoccoli-Rodriguez V, Colombel JF, et al
    The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical T
    Inflamm Bowel Dis. 2019 May 11. pii: 5488461. doi: 10.1093.
    PubMed     Abstract available


  220. DIAB J, Hansen T, Goll R, Stenlund H, et al
    Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State.
    Inflamm Bowel Dis. 2019 May 11. pii: 5488457. doi: 10.1093.
    PubMed     Abstract available


  221. BRENNER EJ, Jhaveri R, Kappelman MD, Gulati AS, et al
    Evaluating Hepatitis B Seroprotection and Revaccination for Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 May 11. pii: 5488459. doi: 10.1093.
    PubMed    


  222. GUERRERO VINSARD D, Wakefield D, Vaziri H, Karagozian R, et al
    Vaccine-Preventable Diseases in Hospitalized Patients With Inflammatory Bowel Disease: A Nationwide Cohort Analysis.
    Inflamm Bowel Dis. 2019 May 8. pii: 5487145. doi: 10.1093.
    PubMed     Abstract available


  223. BOGACH J, Pond G, Esckicioglu C, Seow H, et al
    Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Inflamm Bowel Dis. 2019 May 8. pii: 5486981. doi: 10.1093.
    PubMed     Abstract available


  224. DELDAY M, Mulder I, Logan ET, Grant G, et al
    Reply to the Letter to the Editor of Drs. Sitkin and Pokrotnieks.
    Inflamm Bowel Dis. 2019;25:e72.
    PubMed    


  225. FUKUDA T, Naganuma M, Kanai T
    How Can We Assess "Complete Healing" Beyond Endoscopic Remission?
    Inflamm Bowel Dis. 2019;25:e68.
    PubMed    


  226. BRYANT RV, Schultz CG, Ooi S, Goess C, et al
    Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life.
    Inflamm Bowel Dis. 2019;25:e62-e63.
    PubMed    


  227. DAI C, Jiang M, Huang YH
    The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Inflamm Bowel Dis. 2019;25:e61.
    PubMed    


  228. GREENFEST A, Szvarca D, Clarke L, Tabbara N, et al
    New Vaccine, New Guidelines, Same Problem: The Rates of Herpes Zoster Infection and Vaccination in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e60.
    PubMed    


  229. COUCH DG, Cook H, Ortori C, Barrett D, et al
    Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
    Inflamm Bowel Dis. 2019;25:1006-1018.
    PubMed     Abstract available


  230. CALDERA F, Hayney MS, Cross RK
    Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.
    Inflamm Bowel Dis. 2019;25:955-957.
    PubMed    


  231. MOORE AC, Huang VW, Bourdages R, Fedorak RN, et al
    IBDoc Canadian User Performance Evaluation.
    Inflamm Bowel Dis. 2019;25:1107-1114.
    PubMed     Abstract available


  232. KOTZEV A, Tanchev L, Encheva L, Kovachev N, et al
    Sigmoidouterine Fistula in Crohn's Disease: A First Case Report.
    Inflamm Bowel Dis. 2019;25:e65-e66.
    PubMed    


  233. QAZI T, Verma R, Hamilton MJ, Kaplan ER, et al
    The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:1044-1053.
    PubMed     Abstract available


  234. SADO AI, Kalla R, Sharma A
    A Case of IBD Immunosuppression Related Salmonella Aortitis Requiring Emergency Vascular Grafting.
    Inflamm Bowel Dis. 2019;25:e64.
    PubMed    


  235. SCHMIDT T, Feagins LA
    How Can We Improve to Keep Our Patients Out of the Hospital?
    Inflamm Bowel Dis. 2019;25:980-986.
    PubMed     Abstract available


  236. PARK SH, Aniwan S, Scott Harmsen W, Tremaine WJ, et al
    Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort.
    Inflamm Bowel Dis. 2019;25:1054-1060.
    PubMed     Abstract available


  237. PLEVRIS N, Lyons M, Jenkinson PW, Chuah CS, et al
    Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission.
    Inflamm Bowel Dis. 2019;25:1036-1043.
    PubMed     Abstract available


  238. VAN DEN BRINK G, Stapersma L, Bom AS, Rizopolous D, et al
    Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial.
    Inflamm Bowel Dis. 2019 May 3. pii: 5485288. doi: 10.1093.
    PubMed     Abstract available


  239. GRASS F, Fletcher JG, Alsughayer A, Petersen M, et al
    Development of an Objective Model to Define Near-Term Risk of Ileocecal Resection in Patients with Terminal Ileal Crohn Disease.
    Inflamm Bowel Dis. 2019 May 3. pii: 5485212. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  240. LEONE D, Gilardi D, Corro BE, Menichetti J, et al
    Psychological Functioning of Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Apr 30. pii: 5482244. doi: 10.1093.
    PubMed    


  241. LIMKETKAI BN, Singh S, Jairath V, Sandborn WJ, et al
    US Practice Patterns and Impact of Monitoring for Mucosal Inflammation After Biologic Initiation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Apr 30. pii: 5482264. doi: 10.1093.
    PubMed     Abstract available


  242. DALAL RS, Vajravelu RK, Lewis JD, Lichtenstein GR, et al
    Hospitalization Outcomes for Inflammatory Bowel Disease in Teaching vs Nonteaching Hospitals.
    Inflamm Bowel Dis. 2019 Apr 30. pii: 5482270. doi: 10.1093.
    PubMed     Abstract available


  243. CHOI H, Bou-Abboud Matta C, Fu G, Trichonas G, et al
    Central Retinal Vein Occlusion: A Rare Ocular Complication of Inflammatory Bowel Disease-A Case Series.
    Inflamm Bowel Dis. 2019 Apr 26. pii: 5480053. doi: 10.1093.
    PubMed    


  244. PERL D, Waljee AK, Bishu S, Higgins PDR, et al
    Imaging Features Associated With Failure of Nonoperative Management of Intraabdominal Abscesses in Crohn Disease.
    Inflamm Bowel Dis. 2019 Apr 25. pii: 5479566. doi: 10.1093.
    PubMed     Abstract available


  245. CANETE F, Manosa M, Casanova MJ, Gonzalez-Sueyro RC, et al
    Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.
    Inflamm Bowel Dis. 2019 Apr 22. pii: 5475919. doi: 10.1093.
    PubMed     Abstract available


  246. BOLIA R, Rajanayagam J, Hardikar W, Alex G, et al
    Impact of Changing Treatment Strategies on Outcomes in Pediatric Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Apr 19. pii: 5475303. doi: 10.1093.
    PubMed     Abstract available


  247. AXELRAD JE, Sharma R, Laszkowska M, Packey C, et al
    Increased Healthcare Utilization by Patients With Inflammatory Bowel Disease Covered by Medicaid at a Tertiary Care Center.
    Inflamm Bowel Dis. 2019 Apr 16. pii: 5467405. doi: 10.1093.
    PubMed     Abstract available


  248. TAFT TH, Quinton S, Tomasino K, Craven M, et al
    Letter to the Editor: Patients With Inflammatory Bowel Disease Demonstrate an Inherent Lack of Psychopathology.
    Inflamm Bowel Dis. 2019 Apr 16. pii: 5469113. doi: 10.1093.
    PubMed    


  249. KHAN N, Vallarino C, Lissoos T, Darr U, et al
    Risk of Infection and Types of Infection Among Elderly Patients With Inflammatory Bowel Disease: A Retrospective Database Analysis.
    Inflamm Bowel Dis. 2019 Apr 13. pii: 5455214. doi: 10.1093.
    PubMed     Abstract available


  250. WU B, Tong J, Ran Z
    Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review.
    Inflamm Bowel Dis. 2019 Apr 13. pii: 5455220. doi: 10.1093.
    PubMed     Abstract available


  251. LEWIN SM, McConnell RA, Patel R, Sharpton SR, et al
    Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol.
    Inflamm Bowel Dis. 2019 Apr 13. pii: 5455217. doi: 10.1093.
    PubMed     Abstract available


  252. PAUWELS RWM, de Vries AC, van der Woude CJ
    Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2019;25:e59.
    PubMed    


  253. SHMIDT E, Dulai PS
    Reply to the Letter to the Editor of Dr. Pauwels et al.
    Inflamm Bowel Dis. 2019;25:e58.
    PubMed    


  254. JUN S
    Ethnicity May Be Important for Studying the Role of the Microbiome and Vitamin D Receptor in IBD.
    Inflamm Bowel Dis. 2019;25:e54.
    PubMed    


  255. SZYMCZAK-TOMCZAK A, Krela-Kazmierczak I, Kaczmarek-Rys M, Hryhorowicz S, et al
    Does Only Sex Matter? Complexity of the Association Between Vdr Gene BsmI Single Nucleotide Polymorphism and Immune Response in IBD.
    Inflamm Bowel Dis. 2019;25:e56-e57.
    PubMed    


  256. CHETCUTI ZAMMIT S, McAlindon ME, Hale MF, Sanders DS, et al
    Small Bowel Ulcers on Capsule Endoscopy and Their Significance.
    Inflamm Bowel Dis. 2019;25:e55.
    PubMed    


  257. KANE S
    Leter to the Editor.
    Inflamm Bowel Dis. 2019;25:e52.
    PubMed    


  258. FRANCO DL, Holubar SD, Lightner AL, Lashner BA, et al
    Local Stem Cell Therapy for Crohn's Perianal Fistulae.
    Inflamm Bowel Dis. 2019;25:816-819.
    PubMed    


  259. SCOTT FI, Johnson FR, Bewtra M, Brensinger CM, et al
    Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:925-936.
    PubMed     Abstract available


  260. CHUDY-ONWUGAJE KO, Christian KE, Farraye FA, Cross RK, et al
    A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD.
    Inflamm Bowel Dis. 2019;25:820-830.
    PubMed     Abstract available


  261. CLICK B, Regueiro M
    A Practical Guide to the Safety and Monitoring of New IBD Therapies.
    Inflamm Bowel Dis. 2019;25:831-842.
    PubMed     Abstract available


  262. NUCERA E, Andriollo G, Buonomo A, Di Rienzo A, et al
    Interesting Case of Infliximab IV Type Hypersensitivity.
    Inflamm Bowel Dis. 2019;25:e49-e51.
    PubMed    


  263. MAHADEVAN U, Robinson C, Bernasko N, Boland B, et al
    Erratum: Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.
    Inflamm Bowel Dis. 2019 Apr 4. pii: 5427975. doi: 10.1093.
    PubMed    


  264. ROBERTA N, Valentina B, Luigi M, Carmine P, et al
    Shiga Toxin Producing Escherichia coli-Hemolytic Uremic Syndrome Mimicking Acute Severe Ulcerative Colitis in a Child With Bloody Diarrhea.
    Inflamm Bowel Dis. 2019 Apr 1. pii: 5424809. doi: 10.1093.
    PubMed    


  265. CLICK B, Regueiro M
    The Inflammatory Bowel Disease Medical Home: From Patients to Populations.
    Inflamm Bowel Dis. 2019 Apr 1. pii: 5424811. doi: 10.1093.
    PubMed     Abstract available


  266. BERG DR, Colombel JF, Ungaro R
    The Role of Early Biologic Therapy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Apr 1. pii: 5424853. doi: 10.1093.
    PubMed     Abstract available


  267. FAVALE A, Onali S, Caprioli F, Pugliese D, et al
    Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab.
    Inflamm Bowel Dis. 2019 Apr 1. pii: 5424157. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  268. SEXTON KA, Walker JR, Targownik LE, Graff LA, et al
    The Inflammatory Bowel Disease Symptom Inventory: A Patient-report Scale for Research and Clinical Application.
    Inflamm Bowel Dis. 2019 Mar 27. pii: 5421080. doi: 10.1093.
    PubMed     Abstract available


  269. ZOU ZY, Shen B, Fan JG
    Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 27. pii: 5421081. doi: 10.1093.
    PubMed     Abstract available


  270. ROOSENBOOM B, Wahab PJ, Smids C, Groenen MJM, et al
    Intestinal CD103+CD4+ and CD103+CD8+ T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-up.
    Inflamm Bowel Dis. 2019 Mar 27. pii: 5421083. doi: 10.1093.
    PubMed     Abstract available


  271. MALMBORG P, Mouratidou N, Sachs MC, Hammar U, et al
    Effects of Childhood-onset Inflammatory Bowel Disease on School Performance: A Nationwide Population-based Cohort Study Using Swedish Health and Educational Registers.
    Inflamm Bowel Dis. 2019 Mar 27. pii: 5420619. doi: 10.1093.
    PubMed     Abstract available


  272. OPSTELTEN JL, Vaartjes I, Bots ML, Oldenburg B, et al
    Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study.
    Inflamm Bowel Dis. 2019 Mar 27. pii: 5421033. doi: 10.1093.
    PubMed     Abstract available


  273. HOOPER KM, Casanova V, Kemp S, Staines KA, et al
    The Inflammatory Bowel Disease Drug Azathioprine Induces Autophagy via mTORC1 and the Unfolded Protein Response Sensor PERK.
    Inflamm Bowel Dis. 2019 Mar 19. pii: 5393636. doi: 10.1093.
    PubMed     Abstract available


  274. LEWIS K, Marrie RA, Bernstein CN, Graff LA, et al
    The Prevalence and Risk Factors of Undiagnosed Depression and Anxiety Disorders Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 19. pii: 5388163. doi: 10.1093.
    PubMed     Abstract available


  275. BUCHNER AM
    Confocal Laser Endomicroscopy in the Evaluation of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 16. pii: 5382084. doi: 10.1093.
    PubMed     Abstract available


  276. LIMDI JK, Farraye J, Cannon R, Woodhams E, et al
    Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: What Clinicians (and Patients) Should Know.
    Inflamm Bowel Dis. 2019 Mar 16. pii: 5382083. doi: 10.1093.
    PubMed     Abstract available


  277. LI Y, Liu X
    Shall Patients With a History of Inflammatory Bowel Disease-Related Surgery Be Excluded in the Assessment of Sexual Function?
    Inflamm Bowel Dis. 2019 Mar 15. pii: 5381151. doi: 10.1093.
    PubMed     Abstract available


  278. LASHNER BA, Cominelli F
    Conflicts of Interest in Clinical Practice Guidelines.
    Inflamm Bowel Dis. 2019;25:646.
    PubMed    


  279. SORRENTINO D, Nguyen VQ
    Small Bowel Inflammation in Crohn's Disease and Other Conditions.
    Inflamm Bowel Dis. 2019;25:e46.
    PubMed    


  280. RODRIGUEZ-PALACIOS A, Cominelli F
    Crohn's Disease-Like Ileitis and the Inhibitory Effect of Sucralose on Streptococci.
    Inflamm Bowel Dis. 2019;25:e34-e37.
    PubMed    


  281. GOREN I, Godny L, Reshef L, Yanai H, et al
    Starch Consumption May Modify Antiglycan Antibodies and Fecal Fungal Composition in Patients With Ileo-Anal Pouch.
    Inflamm Bowel Dis. 2019;25:742-749.
    PubMed     Abstract available


  282. ZHAO S, Wang J, Liu Y, Luo L, et al
    Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis.
    Inflamm Bowel Dis. 2019;25:699-707.
    PubMed     Abstract available


  283. WEAVER KN, Gregory M, Syal G, Hoversten P, et al
    Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort.
    Inflamm Bowel Dis. 2019;25:767-774.
    PubMed     Abstract available


  284. DURICOVA D, Dvorakova E, Hradsky O, Mitrova K, et al
    Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation.
    Inflamm Bowel Dis. 2019;25:789-796.
    PubMed     Abstract available


  285. CARUSO ML, Cavalcanti E, Ignazzi A, Lantone G, et al
    Infliximab Has a Number of Well-Described Adverse Effects. Is Myeloid Metaplasia One of These in Elderly Long-standing IBD Patients?
    Inflamm Bowel Dis. 2019;25:e44-e45.
    PubMed    


  286. SHMIDT E, Suarez-Farinas M, Mallette M, Moniz H, et al
    Erectile Dysfunction Is Highly Prevalent in Men With Newly Diagnosed Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 11. pii: 5376643. doi: 10.1093.
    PubMed     Abstract available


  287. FILIPPONE RT, Sahakian L, Apostolopoulos V, Nurgali K, et al
    Eosinophils in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 11. pii: 5374663. doi: 10.1093.
    PubMed     Abstract available


  288. HIRTEN RP, Grinspan A, Fu SC, Luo Y, et al
    Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 10. pii: 5372769. doi: 10.1093.
    PubMed     Abstract available


  289. TAFT TH, Bedell A, Craven MR, Guadagnoli L, et al
    Initial Assessment of Post-traumatic Stress in a US Cohort of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Mar 7. pii: 5370427. doi: 10.1093.
    PubMed     Abstract available


  290. PETITO V, Fiore L, Lopetuso LR, Scaldaferri F, et al
    Commentary to "Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2019 Mar 6. pii: 5370426. doi: 10.1093.
    PubMed    


  291. CHEN C, Hartzema AG, Xiao H, Wei YJ, et al
    Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2019 Mar 6. pii: 5370024. doi: 10.1093.
    PubMed     Abstract available


  292. DAO A, Abidian M, Lestrange A, Mattar M, et al
    Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2019 Mar 6. pii: 5369961. doi: 10.1093.
    PubMed    


  293. MOULTON CD, Hopkins CWP, Mohamedali Z, Powell N, et al
    Out of Sight, Out of Mind: The Limitations of the Hospital Anxiety and Depression Scale in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 2. pii: 5368192. doi: 10.1093.
    PubMed    


  294. MAHADEVAN U, Robinson C, Bernasko N, Boland B, et al
    Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.
    Inflamm Bowel Dis. 2019 Mar 1. pii: 5368148. doi: 10.1093.
    PubMed    


    February 2019
  295. HANSEN TM, Targownik LE, Karimuddin A, Leung Y, et al
    Management of Biological Therapy Before Elective Inflammatory Bowel Disease Surgeries.
    Inflamm Bowel Dis. 2019 Feb 22. pii: 5362644. doi: 10.1093.
    PubMed     Abstract available


  296. YAN P, Wang Y, Meng X, Yang H, et al
    Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Inflamm Bowel Dis. 2019 Feb 22. pii: 5362640. doi: 10.1093.
    PubMed     Abstract available


  297. MARCIL V, Levy E, Amre D, Serban D, et al
    A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?
    Inflamm Bowel Dis. 2019 Feb 22. pii: 5320531. doi: 10.1093.
    PubMed     Abstract available


  298. EAST JE, Boyapati RK, Torres J, Parker CE, et al
    Controversies in Inflammatory Bowel Disease: Exploring Clinical Dilemmas Using Cochrane Reviews.
    Inflamm Bowel Dis. 2019;25:472-478.
    PubMed     Abstract available


  299. KHAN N
    Factors Predicting Severity of Herpes and Improving Herpes Vaccination Among IBD Patients.
    Inflamm Bowel Dis. 2019;25:e24.
    PubMed    


  300. APTE M, Reich J, Zahorian T, Farraye FA, et al
    Improving Vaccination Rates for IBD Patients Through the Use of Local Pharmacies.
    Inflamm Bowel Dis. 2019;25:e19.
    PubMed    


  301. QIN X
    May Dysbiosis Caused by Dietary Chemicals Such as Sucralose and Saccharin Be More Detrimental to the Gut and Health Than Antibiotics? How?
    Inflamm Bowel Dis. 2019;25:e20.
    PubMed    


  302. MAO R, Kurada S, Gordon IO, Baker ME, et al
    The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:421-426.
    PubMed     Abstract available


  303. BRYANT RV, Schultz CG, Ooi S, Goess C, et al
    Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Inflamm Bowel Dis. 2019;25:592-600.
    PubMed     Abstract available


  304. ARMUZZI A, Fiorino G, Variola A, Manetti N, et al
    The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.
    Inflamm Bowel Dis. 2019;25:568-579.
    PubMed     Abstract available


  305. DENSON LA, Jurickova I, Karns R, Shaw KA, et al
    Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:547-560.
    PubMed     Abstract available


  306. QUINN KP, Lightner AL, Faubion WA, Raffals LE, et al
    A Comprehensive Approach to Pouch Disorders.
    Inflamm Bowel Dis. 2019;25:460-471.
    PubMed     Abstract available


  307. NUGENT Z, Singh H, Targownik LE, Bernstein CN, et al
    Herpes Zoster Infection and Herpes Zoster Vaccination in a Population-Based Sample of Persons With IBD: Is There Still an Unmet Need?
    Inflamm Bowel Dis. 2019;25:532-540.
    PubMed     Abstract available


  308. MIZUNO S, Naganuma M, Kanai T
    Idiopathic Thrombocytopenic Purpura Responsive to Surgery for Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:e26.
    PubMed    


  309. NOVELLO M, Shen B, Stocchi L
    Pouchitis as an Indication for Ileal Pouch Surgical Revision.
    Inflamm Bowel Dis. 2019;25:e25.
    PubMed    


  310. GLAPA A, Waraczewski K, Nowak JK, Paszkowski J, et al
    Vitamin K Deficiency in Patients After Restorative Proctocolectomy.
    Inflamm Bowel Dis. 2019;25:e17-e18.
    PubMed    


  311. EL OUALI S, Kessler H, Shen B
    Self-Expandable Metal Stent in the Treatment of Refractory Long Pouch Inlet Stricture.
    Inflamm Bowel Dis. 2019;25:e13-e14.
    PubMed    


  312. DANILUK U, Daniluk J, Kucharski R, Kowalczyk T, et al
    Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn's Disease and Ulcerative Colitis-A Preliminary Study.
    Inflamm Bowel Dis. 2019 Feb 17. pii: 5321879. doi: 10.1093.
    PubMed     Abstract available


  313. BHAT S, Zahorian T, Robert R, Farraye FA, et al
    Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310379. doi: 10.1093.
    PubMed     Abstract available


  314. NEXOE AB, Pilecki B, Von Huth S, Husby S, et al
    Colonic Epithelial Surfactant Protein D Expression Correlates with Inflammation in Clinical Colonic Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310373. doi: 10.1093.
    PubMed     Abstract available


  315. ADEDOKUN OJ, Gunn GR 3rd, Leu JH, Gargano C, et al
    Immunogenicity of Golimumab and its Clinical Relevance in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310409. doi: 10.1093.
    PubMed     Abstract available


  316. DALAL RS, Osterman MT, Buchner AM, Praestgaard A, et al
    A User-Friendly Prediction Tool to Identify Colectomy Risk in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310380. doi: 10.1093.
    PubMed     Abstract available


  317. SHMIDT E, Suarez-Farinas M, Mallette M, Moniz H, et al
    A Longitudinal Study of Sexual Function in Women With Newly Diagnosed Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Feb 6. pii: 5307860. doi: 10.1093.
    PubMed     Abstract available


  318. BRETON J, Kastl A, Hoffmann N, Rogers R, et al
    Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Feb 4. pii: 5306187. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  319. VELASCO RODRIGUEZ-BELVIS M, Viada Bris JF, Palomino Perez L, Munoz Codoceo RA, et al
    Regain of Response to Adalimumab in a Steroid-Dependent Pediatric Patient With Ulcerative Colitis After Undergoing Selective Granulocyte and Monocyte Apheresis.
    Inflamm Bowel Dis. 2019 Jan 30. pii: 5304206. doi: 10.1093.
    PubMed    


  320. BYNDLOSS MX, Litvak Y, Baumler AJ
    Microbiota-nourishing Immunity and Its Relevance for Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Jan 30. pii: 5304210. doi: 10.1093.
    PubMed    


  321. LEONE D, Gilardi D, Corro BE, Menichetti J, et al
    Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients.
    Inflamm Bowel Dis. 2019 Jan 28. pii: 5303250. doi: 10.1093.
    PubMed     Abstract available


  322. VASUDEVAN A, Gibson PR, Van Langenberg DR
    Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jan 25. pii: 5300059. doi: 10.1093.
    PubMed     Abstract available


  323. TACK GJ, de Boer NKH
    Let Us Not Forget HPV Vaccination in Women and Men in IBD.
    Inflamm Bowel Dis. 2019;25:e11.
    PubMed    


  324. WANG X, Guo J, Liu Y, Yu H, et al
    Sucralose Increased Susceptibility to Colitis in Rats.
    Inflamm Bowel Dis. 2019;25:e3-e4.
    PubMed    


  325. RODRIGUEZ-PALACIOS A, Cominelli F
    Myeloperoxidases and Proteobacteria: Reliable Interspecies Biomarkers to Identify and Monitor Pro-inflammatory Diets in Humans.
    Inflamm Bowel Dis. 2019;25:e1-e2.
    PubMed    


  326. BERNSTEIN CN, Shafer LA, Singh H, Targownik L, et al
    Reply to Letter to Editor of Dr. Elia.
    Inflamm Bowel Dis. 2019;25:e9.
    PubMed    


  327. ELIA JR
    IBD Disability Measure: Are Objective Disability Measures and Physical Therapy Strategies Next Logical Steps?
    Inflamm Bowel Dis. 2019;25:e10.
    PubMed    


  328. OPSTELTEN JL, Oldenburg B
    Reply.
    Inflamm Bowel Dis. 2019;25:e5.
    PubMed    


  329. QIN X
    The Effect of Splenda on Gut Microbiota of Humans Could be Much More Detrimental Than in Animals and Deserves More Extensive Research.
    Inflamm Bowel Dis. 2019;25:e7.
    PubMed    


  330. RODRIGUEZ-PALACIOS A, Cominelli F
    Artificial Diets and the Assessment of Negative Effects on the Digestive Health of Humans.
    Inflamm Bowel Dis. 2019;25:e8.
    PubMed    


  331. DOVROLIS N, Drygiannakis I, Filidou E, Kandilogiannakis L, et al
    Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico Approach.
    Inflamm Bowel Dis. 2019;25:217-225.
    PubMed     Abstract available


  332. WEIZMAN AV, Nguyen GC, Seow CH, Targownik L, et al
    Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness Methodology.
    Inflamm Bowel Dis. 2019;25:328-335.
    PubMed     Abstract available


  333. SHEN W, Li Y, Zou Y, Cao L, et al
    Mesenteric Adipose Tissue Alterations in Crohn's Disease Are Associated With the Lymphatic System.
    Inflamm Bowel Dis. 2019;25:283-293.
    PubMed     Abstract available


  334. SCHIRBEL A, Rebert N, Sadler T, West G, et al
    Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy.
    Inflamm Bowel Dis. 2019;25:294-305.
    PubMed     Abstract available


  335. BEN-SHACHAR S, Finezilber Y, Elad H, Rabinowitz K, et al
    Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2019;25:336-344.
    PubMed     Abstract available


  336. BITTON A, Vutcovici M, Lytvyak E, Kachan N, et al
    Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives.
    Inflamm Bowel Dis. 2019;25:403-409.
    PubMed     Abstract available


  337. DURICOVA D, Sarter H, Savoye G, Leroyer A, et al
    Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based Study.
    Inflamm Bowel Dis. 2019;25:394-402.
    PubMed     Abstract available


  338. XU Y, Yang L, An P, Zhou B, et al
    Meta-Analysis: The Influence of Preoperative Infliximab Use on Postoperative Complications of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:261-269.
    PubMed     Abstract available


  339. DEEPAK P, Fowler KJ, Fletcher JG, Bruining DH, et al
    Novel Imaging Approaches in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2019;25:248-260.
    PubMed     Abstract available


  340. SHAFER LA, Walker JR, Restall G, Chhibba T, et al
    Association Between IBD Disability and Reduced Work Productivity (Presenteeism): A Population-Based Study in Manitoba, Canada.
    Inflamm Bowel Dis. 2019;25:352-359.
    PubMed     Abstract available


  341. RIVERA ED, Coffey JC, Walsh D, Ehrenpreis ED, et al
    The Mesentery, Systemic Inflammation, and Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:226-234.
    PubMed     Abstract available


  342. LINSON EA, Hanauer SB
    More Than a Tumor Marker...A Potential Role for Alpha-Feto Protein in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jan 8. pii: 5280837. doi: 10.1093.
    PubMed     Abstract available


  343. NARULA N, Pinto-Sanchez MI, Calo NC, Ford AC, et al
    Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jan 7. pii: 5280101. doi: 10.1093.
    PubMed     Abstract available


  344. MA D, Cao Y, Wang Z, He J, et al
    CCAT1 lncRNA Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier via Downregulating miR-185-3p.
    Inflamm Bowel Dis. 2019 Jan 4. pii: 5273768. doi: 10.1093.
    PubMed     Abstract available


  345. CHOY MC, Seah D, Faleck DM, Shah SC, et al
    Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Jan 3. pii: 5272589. doi: 10.1093.
    PubMed     Abstract available


  346. ARIHIRO S, Nakashima A, Matsuoka M, Suto S, et al
    Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jan 2. pii: 5270748. doi: 10.1093.
    PubMed     Abstract available


  347. RENOUF MJ, Cho YH, McPhee JB
    Emergent Behavior of IBD-Associated Escherichia coli During Disease.
    Inflamm Bowel Dis. 2019;25:33-44.
    PubMed     Abstract available


  348. BUTTO LF, Jia LG, Arseneau KO, Tamagawa H, et al
    Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:14-26.
    PubMed     Abstract available


  349. ZHANG YG, Lu R, Xia Y, Zhou D, et al
    Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses.
    Inflamm Bowel Dis. 2019;25:97-110.
    PubMed     Abstract available


  350. DELDAY M, Mulder I, Logan ET, Grant G, et al
    Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:85-96.
    PubMed     Abstract available


  351. STEINHART AH, Panaccione R, Targownik L, Bressler B, et al
    Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.
    Inflamm Bowel Dis. 2019;25:1-13.
    PubMed     Abstract available


  352. CUSHING KC, Mclean R, McDonald KG, Gustafsson JK, et al
    Predicting Risk of Postoperative Disease Recurrence in Crohn's Disease: Patients With Indolent Crohn's Disease Have Distinct Whole Transcriptome Profiles at the Time of First Surgery.
    Inflamm Bowel Dis. 2019;25:180-193.
    PubMed     Abstract available


  353. SPENCER E, Norris E, Williams C, Dubinsky MC, et al
    The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Inflamm Bowel Dis. 2019;25:142-149.
    PubMed     Abstract available


  354. EL-MATARY W, Walters TD, Huynh HQ, deBruyn J, et al
    Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children.
    Inflamm Bowel Dis. 2019;25:150-155.
    PubMed     Abstract available


  355. SAROLI PALUMBO C, Restellini S, Chao CY, Aruljothy A, et al
    Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.
    Inflamm Bowel Dis. 2019;25:124-133.
    PubMed     Abstract available


  356. LEGA S, Phan BL, Rosenthal CJ, Gordon J, et al
    Proactively Optimized Infliximab Monotherapy Is as Effective as Combination Therapy in IBD.
    Inflamm Bowel Dis. 2019;25:134-141.
    PubMed     Abstract available


  357. DOTSON JL, Kappelman MD, Bricker J, Andridge R, et al
    Multicenter Evaluation of Emergency Department Treatment for Children and Adolescents With Crohn's Disease According to Race/Ethnicity and Insurance Payor Status.
    Inflamm Bowel Dis. 2019;25:194-203.
    PubMed     Abstract available


    December 2018
  358. KARIYAWASAM VC, Kim S, Mourad FH, Selinger CP, et al
    Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 29. pii: 5266808. doi: 10.1093.
    PubMed     Abstract available


  359. HOOPER KM, Barlow PG, Henderson P, Stevens C, et al
    Interactions Between Autophagy and the Unfolded Protein Response: Implications for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 24. pii: 5259659. doi: 10.1093.
    PubMed     Abstract available


  360. BARNES EL, Long MD, Kappelman MD, Martin CF, et al
    High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 22. pii: 5257738. doi: 10.1093.
    PubMed     Abstract available


  361. MACALUSO FS, Maida M, Ventimiglia M, Renna S, et al
    Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis.
    Inflamm Bowel Dis. 2018 Dec 22. pii: 5257772. doi: 10.1093.
    PubMed     Abstract available


  362. LIN SC, Goldowsky A, Papamichael K, Cheifetz AS, et al
    The Treatment of Inflammatory Bowel Disease in Patients With a History of Malignancy.
    Inflamm Bowel Dis. 2018 Dec 22. pii: 5257774. doi: 10.1093.
    PubMed     Abstract available


  363. FUKAURA K, Iboshi Y, Ogino H, Ihara E, et al
    Mucosal Profiles of Immune Molecules Related to T Helper and Regulatory T Cells Predict Future Relapse in Patients With Quiescent Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Dec 20. pii: 5298886. doi: 10.1093.
    PubMed     Abstract available


  364. SITKIN S, Pokrotnieks J
    Gut Microbiota as a Host Defender and a Foe: The 2 Faces of Commensal Bacteroides thetaiotaomicron in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 17. pii: 5250879. doi: 10.1093.
    PubMed    


  365. ASHTON JJ, Borca F, Mossotto E, Phan HTT, et al
    Analysis and Hierarchical Clustering of Blood Results Before Diagnosis in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 17. pii: 5250787. doi: 10.1093.
    PubMed     Abstract available


  366. KRISTENSEN MS, Kjaerulff TM, Ersboll AK, Green A, et al
    The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Inflamm Bowel Dis. 2018 Dec 14. pii: 5247629. doi: 10.1093.
    PubMed     Abstract available


  367. DEBRUYN JCC, Soon IS, Fonseca K, Feng S, et al
    Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 14. pii: 5247477. doi: 10.1093.
    PubMed     Abstract available


  368. PABLA BS, Scoville EA, Sarker S, Dalal RL, et al
    Histoplasmosis as a Complication of Inflammatory Bowel Disease Therapy: A Case Series.
    Inflamm Bowel Dis. 2018 Dec 13. pii: 5244945. doi: 10.1093.
    PubMed    


  369. OBRAZTSOV IV, Shirokikh KE, Obraztsova OI, Shapina MV, et al
    Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Dec 13. pii: 5245415. doi: 10.1093.
    PubMed     Abstract available


  370. SONG G, Fiocchi C, Achkar JP
    Acupuncture in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 11. pii: 5238704. doi: 10.1093.
    PubMed     Abstract available


  371. YANG L, Tang S, Baker SS, Arijs I, et al
    Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome.
    Inflamm Bowel Dis. 2018 Dec 4. pii: 5230141. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  372. PANHWAR MS, Mansoor E, Al-Kindi SG, Sinh P, et al
    Risk of Myocardial Infarction in Inflammatory Bowel Disease: A Population-based National Study.
    Inflamm Bowel Dis. 2018 Nov 30. pii: 5220868. doi: 10.1093.
    PubMed     Abstract available


  373. MALDONADO FJ, Al Bawardy BF, Nehra AK, Lee YS, et al
    Findings of CT-Derived Bone Strength Assessment in Inflammatory Bowel Disease Patients Undergoing CT Enterography in Clinical Practice.
    Inflamm Bowel Dis. 2018 Nov 27. pii: 5209842. doi: 10.1093.
    PubMed     Abstract available


  374. FRIEDMAN S
    A Meta-analysis of Sexual Function in Patients With Inflammatory Bowel Disease: Examining a Small Piece of the Puzzle.
    Inflamm Bowel Dis. 2018 Nov 23. pii: 5203541. doi: 10.1093.
    PubMed    


  375. DIAB J, Al-Mahdi R, Gouveia-Figueira S, Hansen T, et al
    A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression.
    Inflamm Bowel Dis. 2018 Nov 22. pii: 5198657. doi: 10.1093.
    PubMed     Abstract available


  376. SCAIOLI E, Belluzzi A
    Endoscopic and Histological Normalization as a Target to Prevent Clinical Relapse in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Nov 21. pii: 5194185. doi: 10.1093.
    PubMed    


  377. OH SH, Sung YH, Kim I, Sim CK, et al
    Novel Compound Heterozygote Mutation in IL10RA in a Patient With Very Early-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 21. pii: 5194406. doi: 10.1093.
    PubMed     Abstract available



  378. Erratum to Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Nov 19. pii: 5191226. doi: 10.1093.
    PubMed    


  379. VINAYAGA-PAVAN M, Frampton M, Pontikos N, Levine AP, et al
    Elevation in Cell Cycle and Protein Metabolism Gene Transcription in Inactive Colonic Tissue From Icelandic Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Nov 19. pii: 5193210. doi: 10.1093.
    PubMed     Abstract available


  380. KHERA AJ, Chase JW, Salzberg M, Thompson AJV, et al
    Gut-Directed Pelvic Floor Behavioral Treatment for Fecal Incontinence and Constipation in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 19. pii: 5191232. doi: 10.1093.
    PubMed     Abstract available


  381. KELLY OB, Li N, Smith M, Chan J, et al
    The Prevalence and Clinical Associations of Subclinical Sacroiliitis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 14. pii: 5183322. doi: 10.1093.
    PubMed     Abstract available


  382. AHMED Z, Sarvepalli S, Garber A, Regueiro M, et al
    Value-Based Health Care in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 9. pii: 5168541. doi: 10.1093.
    PubMed     Abstract available


  383. VIADA BRIS JF, Velasco Rodriguez-Belvis M, de Lucas Collantes C, Aparicio Lopez C, et al
    Erratum to Ulcerative Colitis and Atypical Hemolytic-Uremic Syndrome: An Unusual But Potentially Life-threatening Complication.
    Inflamm Bowel Dis. 2018 Nov 8. pii: 5167023. doi: 10.1093.
    PubMed    


  384. RAY G, Longworth MS
    Epigenetics, DNA Organization, and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 8. pii: 5166720. doi: 10.1093.
    PubMed     Abstract available


  385. QAZI T, Farraye FA
    Sleep and Inflammatory Bowel Disease: An Important Bi-Directional Relationship.
    Inflamm Bowel Dis. 2018 Nov 2. pii: 5155657. doi: 10.1093.
    PubMed     Abstract available


    October 2018
  386. FEAGAN BG, Schreiber S, Wolf DC, Axler JL, et al
    Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Oct 25. pii: 5144762. doi: 10.1093.
    PubMed     Abstract available


  387. SWAMINATH A, Berlin EP, Cheifetz A, Hoffenberg E, et al
    The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn's and Colitis Foundation.
    Inflamm Bowel Dis. 2018 Oct 24. pii: 5144402. doi: 10.1093.
    PubMed     Abstract available


  388. GHERSIN I, Khateeb N, Katz LH, Daher S, et al
    Anthropometric Measures in Adolescents With Inflammatory Bowel Disease: A Population-Based Study.
    Inflamm Bowel Dis. 2018 Oct 24. pii: 5144270. doi: 10.1093.
    PubMed     Abstract available


  389. DROBIN K, Assadi G, Hong MG, Andersson E, et al
    Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci.
    Inflamm Bowel Dis. 2018 Oct 24. pii: 5144272. doi: 10.1093.
    PubMed     Abstract available


  390. DE JONG DC, Lo Wenberg M, Koumoutsos I, Ray S, et al
    Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity.
    Inflamm Bowel Dis. 2018 Oct 17. pii: 5134157. doi: 10.1093.
    PubMed     Abstract available


  391. POUILLON L, Baumann C, Rousseau H, Choukour M, et al
    Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience.
    Inflamm Bowel Dis. 2018 Oct 16. pii: 5133439. doi: 10.1093.
    PubMed     Abstract available


  392. KATSANOS KH, Saridi M, Albani E, Mantzouranis G, et al
    Sexual Dysfunction in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:2348-2349.
    PubMed    


  393. TINSLEY A, Navabi S, Williams ED, Liu G, et al
    Erratum to Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5128779. doi: 10.1093.
    PubMed    


  394. LUKIN DJ, Lawlor G, Hudesman DP, Durbin L, et al
    Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5124548. doi: 10.1093.
    PubMed     Abstract available


  395. MUNIZ PEDROGO DA, Chen J, Hillmann B, Jeraldo P, et al
    An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5128781. doi: 10.1093.
    PubMed     Abstract available


  396. EGBERG MD, Galanko JA, Barnes EL, Kappelman MD, et al
    Thrombotic and Infectious Risks of Parenteral Nutrition in Hospitalized Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 10. pii: 5126394. doi: 10.1093.
    PubMed     Abstract available


  397. GRINDAL AW, Khan R, Scaffidi MA, Rumman A, et al
    Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5120389. doi: 10.1093.
    PubMed     Abstract available


  398. COTE-DAIGNEAULT J, Bessissow T, Nicolae MV, Nie R, et al
    Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5120076. doi: 10.1093.
    PubMed     Abstract available


  399. REINISCH W, Bressler B, Curtis R, Parikh A, et al
    Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5119830. doi: 10.1093.
    PubMed     Abstract available


  400. TRAN L, Mulligan K
    A Systematic Review of Self-Management Interventions for Children and Adolescents With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5117847. doi: 10.1093.
    PubMed     Abstract available


  401. BATTAT R, Dulai PS, Vande Casteele N, Evans E, et al
    Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5117434. doi: 10.1093.
    PubMed     Abstract available


  402. GREENSTEIN R, Brown S
    A Data-Based Hypothesis That Inflammatory Bowel Disease Unclassified (IBD-U) May Indicate That IBD Is a Spectrum of a Single Infectious Intestinal Disease.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5116939. doi: 10.1093.
    PubMed    


    September 2018
  403. FUKUDA T, Naganuma M, Sugimoto S, Ono K, et al
    Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1.
    Inflamm Bowel Dis. 2018 Sep 27. pii: 5108467. doi: 10.1093.
    PubMed     Abstract available


  404. SELINGER CP, Ochieng AO, George V, Leong RW, et al
    The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios.
    Inflamm Bowel Dis. 2018 Sep 27. pii: 5108473. doi: 10.1093.
    PubMed     Abstract available


  405. SOLANKY D, Pardi DS, Loftus EV Jr, Khanna S, et al
    Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018 Sep 26. pii: 5107525. doi: 10.1093.
    PubMed     Abstract available


  406. HABOUBI N
    Reporting Colonic Biopsies in Patients With Inflammatory Bowel Disease; a Practical Approach.
    Inflamm Bowel Dis. 2018 Sep 25. pii: 5106751. doi: 10.1093.
    PubMed     Abstract available


  407. MAO EJ, Sheibani S, Martin C, Bloomfeld RS, et al
    Preventive Health Care Among Postpartum Women With Inflammatory Bowel Disease: Results From the PIANO Registry.
    Inflamm Bowel Dis. 2018 Sep 25. pii: 5106752. doi: 10.1093.
    PubMed     Abstract available


  408. KHANNA R, Vande Casteele N
    Use of Precision Medicine in Clinical Trials in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Sep 25. pii: 5106774. doi: 10.1093.
    PubMed     Abstract available


  409. KRUGER AJ, Hinton A, Afzali A
    Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Sep 20. pii: 5104366. doi: 10.1093.
    PubMed     Abstract available


  410. ZHENG C, Huang Y, Hu W, Shi J, et al
    Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
    Inflamm Bowel Dis. 2018 Sep 13. pii: 5096668. doi: 10.1093.
    PubMed     Abstract available


  411. MINACAPELLI CD, Bajpai M, Geng X, Van Gurp J, et al
    miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Sep 11. pii: 5094859. doi: 10.1093.
    PubMed     Abstract available


  412. BORREN NZ, Khalili H, Luther J, Colizzo FP, et al
    Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2018 Sep 11. pii: 5094888. doi: 10.1093.
    PubMed     Abstract available


  413. REICH J, Guo L, Groshek J, Weinberg J, et al
    Social Media Use and Preferences in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Sep 7. pii: 5092671. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  414. JACKSON BD, De Cruz P
    Quality of Care in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 29. pii: 5086256. doi: 10.1093.
    PubMed     Abstract available


  415. KAMAL A, Padival R, Lashner B
    Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap.
    Inflamm Bowel Dis. 2018 Aug 29. pii: 5086585. doi: 10.1093.
    PubMed    


  416. AL-BAWARDY B, Ramos GP, Willrich MAV, Jenkins SM, et al
    Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 24. pii: 5079133. doi: 10.1093.
    PubMed     Abstract available


  417. PEREZ-JELDRES T, Tyler CJ, Boyer JD, Karuppuchamy T, et al
    Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts.
    Inflamm Bowel Dis. 2018 Aug 24. pii: 5079145. doi: 10.1093.
    PubMed     Abstract available


  418. FRITZ J, Walia C, Elkadri A, Pipkorn R, et al
    A Systematic Review of Micronutrient Deficiencies in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 21. pii: 5077382. doi: 10.1093.
    PubMed     Abstract available


  419. NISSEN LHC, Derikx LAAP, Jacobs AME, van Herpen CM, et al
    Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2018;24:2015-2026.
    PubMed     Abstract available


  420. DAI C, Jiang M, Sun MJ
    The Effect of Smoking on the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2018 Aug 14. pii: 5074361. doi: 10.1093.
    PubMed    


  421. ISHIKAWA D, Sasaki T, Takahashi M, Kuwahara-Arai K, et al
    The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
    Inflamm Bowel Dis. 2018 Aug 14. pii: 5074053. doi: 10.1093.
    PubMed     Abstract available


  422. GORREPATI VS, Stuart A, Deiling S, Koltun W, et al
    Response to the Letter to the Editor from Dai et al, Regarding "Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients with Ileal Pouch Anal Anastomosis".
    Inflamm Bowel Dis. 2018 Aug 13. pii: 5073207. doi: 10.1093.
    PubMed    


  423. NORGARD BM, Magnussen B, Fedder J, de Silva PS, et al
    The Risk of Elective Abortion in Women With Crohn's Disease and Ulcerative Colitis: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2018 Aug 10. pii: 5069528. doi: 10.1093.
    PubMed     Abstract available


  424. AZUARA D, Ausso S, Rodriguez-Moranta F, Guardiola J, et al
    New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018 Aug 7. pii: 5067818. doi: 10.1093.
    PubMed     Abstract available


  425. BERNARDO S, Fernandes SR, Goncalves AR, Valente A, et al
    Predicting the Course of Disease in Hospitalized Patients With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067145. doi: 10.1093.
    PubMed     Abstract available


  426. SITKIN S, Pokrotnieks J
    Clinical Potential of Anti-inflammatory Effects of Faecalibacterium prausnitzii and Butyrate in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067149. doi: 10.1093.
    PubMed    


  427. GUADAGNO E, De Rosa F, Borrelli G, Luglio G, et al
    High-grade MiNEN in a Long-standing History of Ulcerative Colitis: An Unexpected Evolution.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067338. doi: 10.1093.
    PubMed    


  428. LYNCH B, Roberts A, Lee Grotz V
    Is Splenda, or Sucralose, Causally Linked to Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067397. doi: 10.1093.
    PubMed    


  429. TEN HOVE JR, Bogaerts JMK, Bak MTJ, Lacle MM, et al
    Malignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 1. pii: 5063333. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  430. OUAHED J, Gordon W, Canavan JB, Zhou H, et al
    Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis.
    Inflamm Bowel Dis. 2018 Jul 31. pii: 5062951. doi: 10.1093.
    PubMed     Abstract available


  431. LAMBDIN JT, Borum M
    Cervical Cancer Screening in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 31. pii: 5061940. doi: 10.1093.
    PubMed    


  432. WATT PJ, Irving MA
    A Diagnosis of Inflammatory Bowel Disease and Access to Psychotherapy: Rural Patients Who Accept Treatment Report Psychosomatic Benefits.
    Inflamm Bowel Dis. 2018 Jul 21. pii: 5056917. doi: 10.1093.
    PubMed    


  433. TINSLEY A, Navabi S, Williams ED, Liu G, et al
    Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 18. pii: 5055346. doi: 10.1093.
    PubMed     Abstract available


  434. PORTER RJ, Andrews C, Brice DP, Durum SK, et al
    Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Jul 18. pii: 5055343. doi: 10.1093.
    PubMed     Abstract available



  435. Corrigendum to Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2018 Jul 17. pii: 5054631. doi: 10.1093.
    PubMed    


  436. VOLK N, Siegel CA
    Defining Failure of Medical Therapy for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 16. pii: 5054534. doi: 10.1093.
    PubMed     Abstract available


  437. TORMEY LK, Reich J, Chen YS, Singh A, et al
    Limited Health Literacy Is Associated With Worse Patient-Reported Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 10. pii: 5051146. doi: 10.1093.
    PubMed     Abstract available


  438. BERNSTEIN CN, Hitchon CA, Walld R, Bolton JM, et al
    Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050505. doi: 10.1093.
    PubMed     Abstract available


  439. WREN AA, Bensen R, Sceats L, Dehghan M, et al
    Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050495. doi: 10.1093.
    PubMed     Abstract available


  440. KUENZIG ME, Benchimol EI
    Chronic Opioid Use Among Youth With Inflammatory Bowel Disease: A New Approach Is Needed.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050494. doi: 10.1093.
    PubMed    


  441. REINISCH W, Colombel JF, Gibson PR, Rutgeerts P, et al
    Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab.
    Inflamm Bowel Dis. 2018 Jul 6. pii: 5049378. doi: 10.1093.
    PubMed     Abstract available



  442. Corrigendum to Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049267. doi: 10.1093.
    PubMed    


  443. KHAN N, Trivedi C, Kavani H, Lewis J, et al
    Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049271. doi: 10.1093.
    PubMed     Abstract available



  444. Corrigendum to Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049258. doi: 10.1093.
    PubMed    


  445. MAHADEVAN U, Dubinsky MC, Su C, Lawendy N, et al
    Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Jul 2. pii: 5047917. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  446. SMITS LJT, van Esch AAJ, Derikx LAAP, Boshuizen R, et al
    Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.
    Inflamm Bowel Dis. 2018 Jun 27. pii: 5045878. doi: 10.1093.
    PubMed     Abstract available


  447. SHIVASHANKAR R, Lichtenstein GR
    Mimics of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 27. pii: 5045858. doi: 10.1093.
    PubMed     Abstract available


  448. XUE M, Shi L, Wang W, Chen S, et al
    An Overview of Molecular Profiles in Ulcerative Colitis-Related Cancer.
    Inflamm Bowel Dis. 2018 Jun 25. pii: 5044833. doi: 10.1093.
    PubMed     Abstract available


  449. DE SILVA PS, O'Toole A, Marc LG, Ulysse CA, et al
    Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 22. pii: 5042958. doi: 10.1093.
    PubMed     Abstract available


  450. VIADA BRIS JF, Velasco Rodriguez-Belvis M, de Lucas Collantes C, Aparicio Lopez C, et al
    Ulcerative Colitis and Atypical Hemolytic-Uremic Syndrome: An Unusual But Potentially Life-threating Life Complication.
    Inflamm Bowel Dis. 2018 Jun 20. pii: 5040737. doi: 10.1093.
    PubMed     Abstract available


  451. TAIDA T, Arai M, Fujie M, Akizue N, et al
    Real-time Endoscopy-Guided Measurement of Rectal Mucosal Admittance Is a Novel and Safe Method for Predicting Ulcerative Colitis Relapse.
    Inflamm Bowel Dis. 2018 Jun 19. pii: 5040214. doi: 10.1093.
    PubMed     Abstract available


  452. PICORARO JA, Lee D, Heller CA, Weaver A, et al
    Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD.
    Inflamm Bowel Dis. 2018 Jun 19. pii: 5040260. doi: 10.1093.
    PubMed     Abstract available


  453. BOSSUYT P, Baert F, D'Heygere F, Nakad A, et al
    Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort.
    Inflamm Bowel Dis. 2018 Jun 15. pii: 5038936. doi: 10.1093.
    PubMed     Abstract available


  454. LEE CK, Melmed GY, Mann A, Danovitch I, et al
    A Multidisciplinary Approach to Biopsychosocial Care for Adults With Inflammatory Bowel Disease: A Pilot Study.
    Inflamm Bowel Dis. 2018 Jun 15. pii: 5038934. doi: 10.1093.
    PubMed     Abstract available


  455. PHILPOTT JR, Kurowski JA
    Challenges in Transitional Care in Inflammatory Bowel Disease: A Review of the Current Literature in Transition Readiness and Outcomes.
    Inflamm Bowel Dis. 2018 Jun 11. pii: 5035657. doi: 10.1093.
    PubMed     Abstract available


  456. SLONIM-NEVO V, Sarid O, Friger M, Schwartz D, et al
    Effect of Social Support on Psychological Distress and Disease Activity in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018;24:1389-1400.
    PubMed     Abstract available


  457. TYLER CJ, Perez-Jeldres T, Ehinger E, Capaldo B, et al
    Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 8. pii: 5034710. doi: 10.1093.
    PubMed     Abstract available


  458. WHITEOAK SR, Claridge A, Balendran CA, Harris RJ, et al
    MicroRNA-31 Targets Thymic Stromal Lymphopoietin in Mucosal Infiltrated CD4+ T Cells: A Role in Achieving Mucosal Healing in Ulcerative Colitis?
    Inflamm Bowel Dis. 2018 Jun 8. pii: 5034803. doi: 10.1093.
    PubMed     Abstract available


  459. WHALEY KG, Rosen MJ
    Contemporary Medical Management of Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Jun 7. pii: 5034511. doi: 10.1093.
    PubMed     Abstract available


  460. RYAN E, McNicholas D, Creavin B, Kelly ME, et al
    Sarcopenia and Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Jun 7. pii: 5034590. doi: 10.1093.
    PubMed     Abstract available


  461. BLAZQUEZ ML, Hernani MT, Calatayud GA, Gonzalez-Pinto LC, et al
    Transition Care Program of Adolescents With Inflammatory Bowel Disease: Perceptions From A Survey for Patients.
    Inflamm Bowel Dis. 2018 Jun 5. pii: 5033090. doi: 10.1093.
    PubMed    


  462. ATREJA A
    Smarter Care for Patients With Inflammatory Bowel Disease: A Necessity for IBD Home, Value-Based Health Care and Treat-to-Target Strategies.
    Inflamm Bowel Dis. 2018 Jun 4. pii: 5032596. doi: 10.1093.
    PubMed    


  463. KELSO M, Feagins LA
    Can Smartphones Help Deliver Smarter Care for Patients With Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Jun 4. pii: 5032595. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  464. ANDERSON A, Click B, Ramos-Rivers C, Koutroubakis IE, et al
    The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 31. pii: 5025926. doi: 10.1093.
    PubMed     Abstract available


  465. WINTHROP KL, Melmed GY, Vermeire S, Long MD, et al
    Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025191. doi: 10.1093.
    PubMed     Abstract available


  466. WIERSTRA K, Sutton R, Bal J, Ismond K, et al
    Innovative Online Educational Portal Improves Disease-Specific Reproductive Knowledge Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025410. doi: 10.1093.
    PubMed     Abstract available


  467. CHANDRADEVAN R, Hofmekler T, Mondal K, Harun N, et al
    Evolution of Pediatric Inflammatory Bowel Disease Unclassified (IBD-U): Incorporated With Serological and Gene Expression Profiles.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025792. doi: 10.1093.
    PubMed     Abstract available


  468. ELIA J, Kane S
    Adult Inflammatory Bowel Disease, Physical Rehabilitation, and Structured Exercise.
    Inflamm Bowel Dis. 2018 May 29. pii: 5020214. doi: 10.1093.
    PubMed     Abstract available


  469. CHUDY-ONWUGAJE K, Abutaleb A, Buchwald A, Langenberg P, et al
    Age Modifies the Association Between Depressive Symptoms and Adherence to Self-Testing With Telemedicine in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 28. pii: 5017268. doi: 10.1093.
    PubMed     Abstract available


  470. KHANNA R, Narula N, Feagan BG
    The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 28. pii: 5017276. doi: 10.1093.
    PubMed     Abstract available


  471. HOSOE N, Nakano M, Takeuchi K, Endo Y, et al
    Establishment of a Novel Scoring System for Colon Capsule Endoscopy to Assess the Severity of Ulcerative Colitis-Capsule Scoring of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 26. pii: 5011158. doi: 10.1093.
    PubMed     Abstract available


  472. BESSISSOW T, Dulai PS, Restellini S, Landry T, et al
    Comparison of Endoscopic Dysplasia Detection Techniques in Patients With Ulcerative Colitis: A Systematic Review and Network Meta-analysis.
    Inflamm Bowel Dis. 2018 May 25. pii: 5004810. doi: 10.1093.
    PubMed     Abstract available


  473. SOFIA MA, Ciorba MA, Meckel K, Lim CK, et al
    Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 22. pii: 5001501. doi: 10.1093.
    PubMed     Abstract available


  474. PENG K, Qian X, Huang Z, Lu J, et al
    Umbilical Cord Blood Transplantation Corrects Very Early-Onset Inflammatory Bowel Disease in Chinese Patients With IL10RA-Associated Immune Deficiency.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999329. doi: 10.1093.
    PubMed     Abstract available


  475. BOSCH S, van Gaal N, Zuurbier RP, Covington JA, et al
    Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999303. doi: 10.1093.
    PubMed     Abstract available


  476. SPAGNUOLO R, Dattilo V, D'Antona L, Cosco C, et al
    Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999450. doi: 10.1093.
    PubMed     Abstract available


  477. DORREEN A, Heisler C, Jones J
    Treatment of Inflammatory Bowel Disease in the Older Patient.
    Inflamm Bowel Dis. 2018;24:1155-1166.
    PubMed     Abstract available


  478. SZETO W, van der Bent A, Petty CR, Reich J, et al
    Use of Social Media for Health-Related Tasks by Adolescents With Inflammatory Bowel Disease: A Step in the Pathway of Transition.
    Inflamm Bowel Dis. 2018;24:1114-1122.
    PubMed     Abstract available


  479. SUH JH, Degagne E, Gleghorn EE, Setty M, et al
    Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.
    Inflamm Bowel Dis. 2018;24:1321-1334.
    PubMed     Abstract available


  480. DIBLEY L, Czuber-Dochan W, Woodward S, Wade T, et al
    Development and Psychometric Properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A New Tool to Measure Disease-Specific Distress.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999398. doi: 10.1093.
    PubMed     Abstract available


  481. KOPYLOV U, Verstockt B, Biedermann L, Sebastian S, et al
    Effectiveness and Safety of Vedolizumab in Anti-TNF-Naive Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999380. doi: 10.1093.
    PubMed     Abstract available


  482. SHMIDT E, Kochhar G, Hartke J, Chilukuri P, et al
    Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999184. doi: 10.1093.
    PubMed     Abstract available


  483. MITCHELL NE, Harrison N, Junga Z, Singla M, et al
    Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999386. doi: 10.1093.
    PubMed     Abstract available


  484. KHANNA R, Zou G, Feagan BG
    Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future Solutions.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999190. doi: 10.1093.
    PubMed     Abstract available


  485. ZHANG M, Merlin D
    Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999330. doi: 10.1093.
    PubMed     Abstract available


  486. ABUTALEB A, Buchwald A, Chudy-Onwugaje K, Langenberg P, et al
    Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999387. doi: 10.1093.
    PubMed     Abstract available


  487. MERKER AM, Riaz M, Friedman S, Allegretti JR, et al
    Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999337. doi: 10.1093.
    PubMed     Abstract available


  488. BARNES EL, Kochar B, Long MD, Pekow J, et al
    Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999440. doi: 10.1093.
    PubMed     Abstract available


  489. NAVABI S, Gorrepati VS, Yadav S, Chintanaboina J, et al
    Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999008. doi: 10.1093.
    PubMed     Abstract available


  490. HARTMAN DJ, Binion DG, Regueiro MD, Miller C, et al
    Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998978. doi: 10.1093.
    PubMed     Abstract available


  491. YUNG DE, Horesh N, Lightner AL, Ben-Horin S, et al
    Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998839. doi: 10.1093.
    PubMed     Abstract available


  492. LIU R, Tang A, Wang X, Shen S, et al
    Assessment of Quality of Life in Chinese Patients With Inflammatory Bowel Disease and their Caregivers.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999056. doi: 10.1093.
    PubMed     Abstract available


  493. ZHENG C, Huang Y, Ye Z, Wang Y, et al
    Infantile Onset Intractable Inflammatory Bowel Disease Due to Novel Heterozygous Mutations in TNFAIP3 (A20).
    Inflamm Bowel Dis. 2018 May 17. pii: 4999659. doi: 10.1093.
    PubMed     Abstract available


  494. HEMPERLY A, Sandborn WJ, Vande Casteele N
    Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998913. doi: 10.1093.
    PubMed     Abstract available


  495. KOSLOWSKY B, Grisaru-Granovsky S, Livovsky DM, Milgrom Y, et al
    Pregnancy-Onset Inflammatory Bowel Disease: A Subtle Diagnosis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998813. doi: 10.1093.
    PubMed     Abstract available


  496. AL-AMODI O, Jodeleit H, Beigel F, Wolf E, et al
    CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998980. doi: 10.1093.
    PubMed     Abstract available


  497. RESTELLINI S, Khanna R, Afif W
    Therapeutic Drug Monitoring With Ustekinumab and Vedolizumab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999007. doi: 10.1093.
    PubMed     Abstract available


  498. GORREPATI VS, Stuart A, Deiling S, Koltun W, et al
    Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999006. doi: 10.1093.
    PubMed     Abstract available


  499. DAI C, Jiang M, Sun MJ
    Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999019. doi: 10.1093.
    PubMed    


  500. MOTTA JP, Allain T, Green-Harrison LE, Groves RA, et al
    Iron Sequestration in Microbiota Biofilms As A Novel Strategy for Treating Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4997020. doi: 10.1093.
    PubMed     Abstract available


  501. MADSEN KG, Pottegard A, Hallas J, Kjeldsen J, et al
    Treatment Failure of TNF-alpha Inhibitors in Obese Patients With Inflammatory Bowel Disease-A Cohort Study.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998912. doi: 10.1093.
    PubMed     Abstract available


  502. COLOMBEL JF
    Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998802. doi: 10.1093.
    PubMed     Abstract available


  503. LIGHTNER AL
    A Cell-Based Approach to the Treatment of Inflammatory Bowel Disease-Entering an Era of Regenerative Medicine.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999009. doi: 10.1093.
    PubMed     Abstract available


  504. JIAN L, Anqi H, Gang L, Litian W, et al
    Food Exclusion Based on IgG Antibodies Alleviates Symptoms in Ulcerative Colitis: A Prospective Study.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996921. doi: 10.1093.
    PubMed     Abstract available


  505. ROBERTS RL, Wallace MC, Seinen ML, van Bodegraven AA, et al
    Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996867. doi: 10.1093.
    PubMed     Abstract available


  506. LI L, Huang S, Wang H, Chao K, et al
    Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996911. doi: 10.1093.
    PubMed     Abstract available


  507. WEIMERS P, Halfvarson J, Sachs MC, Saunders-Pullman R, et al
    Inflammatory Bowel Disease and Parkinson's Disease: A Nationwide Swedish Cohort Study.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996912. doi: 10.1093.
    PubMed     Abstract available


  508. BEGGS AD, James J, Caldwell G, Prout T, et al
    Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia.
    Inflamm Bowel Dis. 2018 May 14. pii: 4995684. doi: 10.1093.
    PubMed     Abstract available


  509. BIANCARDI AL, Zaltman C, Troncoso LL, Luiz RR, et al
    The Role of Clinical-Demographic Characteristics in Ophthalmic Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 11. pii: 4995039. doi: 10.1093.
    PubMed    


  510. MOON CM, Kim SW, Ahn JB, Ma HW, et al
    Deep Resequencing of Ulcerative Colitis-Associated Genes Identifies Novel Variants in Candidate Genes in the Korean Population.
    Inflamm Bowel Dis. 2018 May 4. pii: 4992873. doi: 10.1093.
    PubMed     Abstract available


  511. ROBLIN X, Riviere P, Flamant M, Veyrard P, et al
    Proactive Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 3. pii: 4992140. doi: 10.1093.
    PubMed     Abstract available


  512. WENG MT, Park SH, Matsuoka K, Tung CC, et al
    Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study.
    Inflamm Bowel Dis. 2018 May 3. pii: 4991928. doi: 10.1093.
    PubMed     Abstract available


  513. BARBER GE, Hendler S, Okafor P, Limsui D, et al
    Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis.
    Inflamm Bowel Dis. 2018 May 2. pii: 4990922. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  514. OKABAYASHI S, Kobayashi T, Nakano M, Toyonaga T, et al
    A Simple 1-Day Colon Capsule Endoscopy Procedure Demonstrated to be a Highly Acceptable Monitoring Tool for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990576. doi: 10.1093.
    PubMed     Abstract available


  515. SPENCER EA, Davis SM, Mack DR, Boyle BM, et al
    Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990334. doi: 10.1093.
    PubMed     Abstract available


  516. THEODORAKI E, Orfanoudaki E, Foteinogiannopoulou K, Koutroubakis IE, et al
    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990625. doi: 10.1093.
    PubMed     Abstract available


  517. LEWIS JD
    Inflammatory Bowel Disease Care: What to Do When There Is a Breach of Contract between the Patient and Physician?
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990352. doi: 10.1093.
    PubMed     Abstract available


  518. BURKE KE, Khalili H, Garber JJ, Haritunians T, et al
    Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990575. doi: 10.1093.
    PubMed     Abstract available


  519. PATIL SA, Cross RK
    Current Landscape of Telemedicine Practice in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 28. pii: 4989997. doi: 10.1093.
    PubMed     Abstract available


  520. WU B, Wang Z, Zhang Q
    Cost-Effectiveness of Different Strategies for the Treatment of Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 27. pii: 4989472. doi: 10.1093.
    PubMed     Abstract available


  521. CHI LY, Zitomersky NL, Liu E, Tollefson S, et al
    The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4987131. doi: 10.1093.
    PubMed     Abstract available


  522. KATSANOS KH, Kyriakidi K, Skamnelos A, Christodoulou DK, et al
    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4990626. doi: 10.1093.
    PubMed    


  523. RAMOS GP, Stroh G, Al-Bawardy B, Faubion WA, et al
    Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4987150. doi: 10.1093.
    PubMed     Abstract available


  524. DIEDEREN K, Krom H, Koole JCD, Benninga MA, et al
    Diet and Anthropometrics of Children With Inflammatory Bowel Disease: A Comparison With the General Population.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985538. doi: 10.1093.
    PubMed     Abstract available


  525. GREENER T, Kabakchiev B, Hillary Steinhart A, Silverberg MS, et al
    Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985513. doi: 10.1093.
    PubMed     Abstract available


  526. KHAN N, Trivedi C, Shah Y, Cole E, et al
    The Natural History of Newly Diagnosed Ulcerative Colitis in Patients with Concomitant Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985719. doi: 10.1093.
    PubMed     Abstract available


  527. DANESE S, D'Amico F, Bonovas S, Peyrin-Biroulet L, et al
    Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985510. doi: 10.1093.
    PubMed     Abstract available


  528. LEGA S, Dubinsky MC
    What Are the Targets of Inflammatory Bowel Disease Management.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985529. doi: 10.1093.
    PubMed     Abstract available


  529. BERINSTEIN JA, Waljee AK, Stidham RW, Higgins PDR, et al
    The IBD SGI Diagnostic Test Is Frequently Used by Non-gastroenterologists to Screen for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e18.
    PubMed    


  530. CHIBA M, Sugawara T, Komatsu M, Tozawa H, et al
    Onset of Ulcerative Colitis in the Second Trimester after Emesis Gravidarum: Treatment with Plant-based Diet.
    Inflamm Bowel Dis. 2018;24:e8-e9.
    PubMed    


  531. ROLLI V, Macquin C, Kokten T, Hablot J, et al
    Zinc-Alpha-2-Glycoprotein in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e10.
    PubMed    


  532. KOCHHAR G, Steele S, Sanaka M, Gorgun E, et al
    Endoscopic Submucosal Dissection for Flat Colonic Polyps in Patients With Inflammatory Bowel Disease, A Single-Center Experience.
    Inflamm Bowel Dis. 2018;24:e14-e15.
    PubMed    


  533. SHERMAN HOREV H, Rabinowitz KM, Elad H, Barkan R, et al
    Increase in Processing Factors Is Involved in Skewed MicroRNA Expression in Patients with Ulcerative Colitis Who Develop Small Intestine Inflammation after Pouch Surgery.
    Inflamm Bowel Dis. 2018;24:1045-1054.
    PubMed     Abstract available


  534. SULLIVAN SN
    Bullous Pyoderma Gangrenosum and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e16-e17.
    PubMed    


  535. GAMWELL KL, Baudino MN, Bakula DM, Sharkey CM, et al
    Perceived Illness Stigma, Thwarted Belongingness, and Depressive Symptoms in Youth With Inflammatory Bowel Disease (IBD).
    Inflamm Bowel Dis. 2018;24:960-965.
    PubMed     Abstract available


  536. YE L, Jiang Z, Liu J, Zhou W, et al
    Is There a New Classification of Inflammatory Bowel Disease (IBD)-Adult-Onset Mixed IBD.
    Inflamm Bowel Dis. 2018;24:e19-e20.
    PubMed    


  537. KNOWLES SR, Keefer L, Wilding H, Hewitt C, et al
    Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II.
    Inflamm Bowel Dis. 2018;24:966-976.
    PubMed     Abstract available


  538. BETTNER W, Rizzo A, Brant S, Dudley-Brown S, et al
    Low Incidence of Dysplasia and Colorectal Cancer Observed among Inflammatory Bowel Disease Patients with Prolonged Colonic Diversion.
    Inflamm Bowel Dis. 2018;24:1092-1098.
    PubMed     Abstract available


  539. MARIABEATRICE P, Andrea I, Giuseppe L, Michela M, et al
    Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.
    Inflamm Bowel Dis. 2018 Apr 23. pii: 4982709. doi: 10.1093.
    PubMed     Abstract available


  540. ADHATAMSOONTRA P, Silverman AL, Doria NA, Alsulami N, et al
    A Clouded Picture: Online Resources in IBD Lack Patient-Centered Language.
    Inflamm Bowel Dis. 2018;24:e1.
    PubMed    


  541. SEVERS M, Spekhorst LM, Mangen MJ, Dijkstra G, et al
    Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies.
    Inflamm Bowel Dis. 2018 Apr 21. pii: 4980986. doi: 10.1093.
    PubMed     Abstract available


  542. AKHUEMONKHAN E, Parian A, Carson KA, Hutfless S, et al
    Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969822. doi: 10.1093.
    PubMed     Abstract available


  543. MEIJER B, Mulder CJJ, Bouma G, Ponsioen CY, et al
    Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969999. doi: 10.1093.
    PubMed     Abstract available


  544. AUTH MK, Bunn SK, Protheroe AL, Williams LJ, et al
    Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969914. doi: 10.1093.
    PubMed     Abstract available


  545. GULATI S, Emmanuel A, Burt M, Dubois P, et al
    Outcomes of Endoscopic Resections of Large Laterally Spreading Colorectal Lesions in Inflammatory Bowel Disease: a Single United Kingdom Center Experience.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969983. doi: 10.1093.
    PubMed     Abstract available


  546. SHUTKEVER O, Gracie DJ, Young C, Wood HM, et al
    No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4970060. doi: 10.1093.
    PubMed     Abstract available


  547. CARD T, Xu J, Liang H, Bhayat F, et al
    What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn's Disease Treated With Vedolizumab?
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969878. doi: 10.1093.
    PubMed     Abstract available


  548. HOSOMI S, Watanabe K, Nishida Y, Yamagami H, et al
    Combined Infection of Human Herpes Viruses: A Risk Factor for Subsequent Colectomy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969863. doi: 10.1093.
    PubMed     Abstract available


  549. VAN DE VONDEL S, Baert F, Reenaers C, Vanden Branden S, et al
    Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969974. doi: 10.1093.
    PubMed     Abstract available


  550. FLYNN AD, Valentine JF
    Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969996. doi: 10.1093.
    PubMed     Abstract available


  551. WENTWORTH BJ, Buerlein RCD, Tuskey AG, Overby MA, et al
    Nonadherence to Biologic Therapies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969742. doi: 10.1093.
    PubMed     Abstract available


  552. DUBINSKY MC, Cross RK, Sandborn WJ, Long M, et al
    Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969986. doi: 10.1093.
    PubMed     Abstract available


  553. BERNSTEIN CN, Zhang L, Lix LM, Graff LA, et al
    The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969741. doi: 10.1093.
    PubMed     Abstract available


  554. MARK-CHRISTENSEN A, Laurberg S, Haboubi N
    Dysplasia in Inflammatory Bowel Disease: Historical Review, Critical Histopathological Analysis, and Clinical Implications.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969836. doi: 10.1093.
    PubMed     Abstract available


  555. BUER LCT, Hoivik ML, Warren DJ, Medhus AW, et al
    Combining Anti-TNF-alpha and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series.
    Inflamm Bowel Dis. 2018 Apr 12. pii: 4969708. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  556. GU P, Kuenzig ME, Kaplan GG, Pimentel M, et al
    Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2018 Mar 30. pii: 4916092. doi: 10.1093.
    PubMed     Abstract available


  557. DE SOUZA HSP, Fiocchi C
    Network Medicine: A Mandatory Next Step for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:671-679.
    PubMed     Abstract available


  558. KNOWLES SR, Graff LA, Wilding H, Hewitt C, et al
    Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I.
    Inflamm Bowel Dis. 2018;24:742-751.
    PubMed     Abstract available


  559. VENKATESWARAN S, Prince J, Cutler DJ, Marigorta UM, et al
    Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:829-838.
    PubMed     Abstract available


  560. LEE WJ, Lee TA, Calip GS, Suda KJ, et al
    Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:883-891.
    PubMed     Abstract available


  561. CHRISTENSEN B, Colman RJ, Micic D, Gibson PR, et al
    Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
    Inflamm Bowel Dis. 2018;24:849-860.
    PubMed     Abstract available


  562. VORTIA E, Uko VE, Yen-Lieberman B, Frawley J, et al
    Low Indeterminate Rates Associated With Use of the QuantiFERON-TB Gold In-Tube Test in Children With Inflammatory Bowel Disease on Long-term Infliximab.
    Inflamm Bowel Dis. 2018;24:877-882.
    PubMed     Abstract available


  563. STEINHART AH
    Exit Strategies for Biologic Therapy in IBD: Is It Too Soon to Stop?
    Inflamm Bowel Dis. 2018;24:669-670.
    PubMed    


  564. IRVING PM, Iqbal T, Nwokolo C, Subramanian S, et al
    A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Mar 10. pii: 4925788. doi: 10.1093.
    PubMed     Abstract available


  565. SHIRAI S, Hara M, Sakata Y, Tsuruoka N, et al
    Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2018 Mar 9. pii: 4925593. doi: 10.1093.
    PubMed     Abstract available


  566. MOUCHLI MA, Singh S, Boardman L, Bruining DH, et al
    Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924363. doi: 10.1093.
    PubMed     Abstract available


  567. AARDOOM MA, Linda Joosse ME, de Vries ACH, Levine A, et al
    Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924482. doi: 10.1093.
    PubMed     Abstract available


  568. MARQUES DA COSTA P, Correia L, Correia LA
    The Complexity of Renal Involvment in IBD-C3 Glomerulopathy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924366. doi: 10.1093.
    PubMed    


  569. LITSTER B, Bernstein CN, Graff LA, Walker JR, et al
    Validation of the PHQ-9 for Suicidal Ideation in Persons with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924383. doi: 10.1093.
    PubMed     Abstract available


  570. KHAN N, Trivedi C, Shah Y, Patel D, et al
    The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924495. doi: 10.1093.
    PubMed     Abstract available


  571. LIGHTNER AL, Mathis KL, Tse CS, Pemberton JH, et al
    Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2018 Mar 2. pii: 4917693. doi: 10.1093.
    PubMed     Abstract available


  572. DANION P, Buisson A, Roblin X, Mathieu N, et al
    IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Mar 1. pii: 4916100. doi: 10.1093.
    PubMed     Abstract available


  573. PATEL P, Yarur A, Dalal S, Sakuraba A, et al
    Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
    Inflamm Bowel Dis. 2018 Mar 1. pii: 4916098. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  574. KAMMERLANDER H, Nielsen J, Kjeldsen J, Knudsen T, et al
    Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Feb 28. pii: 4913664. doi: 10.1093.
    PubMed     Abstract available


  575. DA SILVA S, Keita AV, Mohlin S, Pahlman S, et al
    A Novel Topical PPARgamma Agonist Induces PPARgamma Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
    Inflamm Bowel Dis. 2018 Feb 24. pii: 4909417. doi: 10.1093.
    PubMed     Abstract available


  576. REZAIE A, Gu P, Kaplan GG, Pimentel M, et al
    Dyssynergic Defecation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2018 Feb 24. pii: 4909412. doi: 10.1093.
    PubMed     Abstract available


  577. ZAMORA C, Canto E, Nieto JC, Garcia-Planella E, et al
    Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Feb 23. pii: 4908015. doi: 10.1093.
    PubMed     Abstract available


  578. KATSANOS KH, Papamichael K, Cheifetz AS, Christodoulou DK, et al
    Full Interchangeability in Regards to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:465-466.
    PubMed    


  579. UHLIG HH
    Mendelian Diseases and Inflammatory Bowel Disease-Data Mining for Genetic Risk and Disease-Associated Confounders.
    Inflamm Bowel Dis. 2018;24:467-470.
    PubMed    


  580. HAN L, Maciejewski M, Brockel C, Afzelius L, et al
    Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:471-481.
    PubMed     Abstract available


  581. FIORINO G, Ruiz-Arguello MB, Maguregui A, Nagore D, et al
    Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:601-606.
    PubMed     Abstract available


  582. EWELUKWA O, Perez R, Carter LE, Fernandez A, et al
    Incorporation of Scribes Into the Inflammatory Bowel Disease Clinic Improves Quality of Care and Physician Productivity.
    Inflamm Bowel Dis. 2018;24:552-557.
    PubMed     Abstract available


  583. DE ANGELIS PM, Schjolberg AR, Hughes JB, Huitfeldt HS, et al
    Nondysplastic Ulcerative Colitis Has High Levels of the Homologous Recombination Repair Protein NUCKS1 and Low Levels of the DNA Damage Marker Gamma-H2AX.
    Inflamm Bowel Dis. 2018;24:593-600.
    PubMed     Abstract available


  584. BHANDARI S, Saeian K, Stein D
    Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018;24:661.
    PubMed    


  585. DAI C, Cao Q, Sun MJ
    Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018;24:662.
    PubMed    


  586. ZHOU F, Hamza T, Fleur AS, Zhang Y, et al
    Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.
    Inflamm Bowel Dis. 2018;24:573-582.
    PubMed     Abstract available


  587. SAUER CG, Loop MS, Venkateswaran S, Tangpricha V, et al
    Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease Activity in Pediatric Patients With Newly Diagnosed Treatment Naive Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:641-650.
    PubMed     Abstract available


  588. OPSTELTEN JL, Chan SSM, Hart AR, van Schaik FDM, et al
    Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis in European Populations: A Nested Case-Control Study.
    Inflamm Bowel Dis. 2018;24:633-640.
    PubMed     Abstract available


  589. NORDENVALL C, Olen O, Johan Nilsson P, Ekbom A, et al
    Restorative Surgery in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis Following a Colectomy.
    Inflamm Bowel Dis. 2018;24:624-632.
    PubMed     Abstract available


  590. SHAH SC, Naymagon S, Panchal HJ, Sands BE, et al
    Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis.
    Inflamm Bowel Dis. 2018;24:651-659.
    PubMed     Abstract available


  591. GONCALVES P, Araujo JR, Di Santo JP
    A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:558-572.
    PubMed     Abstract available


  592. KANE S
    Letter to the Editor: Missed Meals While Hospitalized for UC.
    Inflamm Bowel Dis. 2018;24:660.
    PubMed    


  593. FUHLER GM, van der Giessen J, van der Woude CJ, Peppelenbosch MP, et al
    Correlating Fecal Calprotectin With Hemoglobin Levels Within 1 Sample.
    Inflamm Bowel Dis. 2018;24:663.
    PubMed    


    January 2018
  594. KANG B, Lee Y, Lee K, Choi YO, et al
    Long-term Outcomes After Switching to CT-P13 in Pediatric-Onset Inflammatory Bowel Disease: A Single-Center Prospective Observational Study.
    Inflamm Bowel Dis. 2018 Jan 30. pii: 4829375. doi: 10.1093.
    PubMed     Abstract available


  595. MOSHER CA, Brown GR, Weideman RA, Crook TW, et al
    Incidence of Colorectal Cancer and Extracolonic Cancers in Veteran Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jan 30. pii: 4829349. doi: 10.1093.
    PubMed     Abstract available


  596. RAO BB, Lashner B, Kowdley KV
    Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Trasnplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018;24:269-276.
    PubMed     Abstract available


  597. O'TOOLE A, de Silva PS, Marc LG, Ulysse CA, et al
    Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale.
    Inflamm Bowel Dis. 2018;24:310-316.
    PubMed     Abstract available


  598. HUGUET M, Pereira B, Goutte M, Goutorbe F, et al
    Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:261-268.
    PubMed     Abstract available


  599. SCOTT FI, Shah Y, Lasch K, Luo M, et al
    Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model.
    Inflamm Bowel Dis. 2018;24:286-295.
    PubMed     Abstract available


  600. YARLAS A, D'Haens G, Willian MK, Teynor M, et al
    Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.
    Inflamm Bowel Dis. 2018;24:450-463.
    PubMed     Abstract available


  601. LARSEN L, Drewes AM, Broberg MCH, Fallingborg J, et al
    Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014.
    Inflamm Bowel Dis. 2018;24:433-439.
    PubMed     Abstract available


  602. PIESTER T, Frymoyer A, Christofferson M, Yu H, et al
    A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:227-234.
    PubMed     Abstract available


  603. GOYAL A, Yeh A, Bush BR, Firek BA, et al
    Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:410-421.
    PubMed     Abstract available


  604. HABERMAN Y, BenShoshan M, Di Segni A, Dexheimer PJ, et al
    Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.
    Inflamm Bowel Dis. 2018;24:346-360.
    PubMed     Abstract available


  605. MACALUSO FS, Sapienza C, Ventimiglia M, Renna S, et al
    The Addition of an Immunosuppressant After Loss of Response to Anti-TNFalpha Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.
    Inflamm Bowel Dis. 2018;24:394-401.
    PubMed     Abstract available


  606. ROLSTON VS, Boroujerdi L, Long MD, McGovern DPB, et al
    The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study.
    Inflamm Bowel Dis. 2018;24:387-393.
    PubMed     Abstract available


  607. PRATT PK JR, David N, Weber HC, Little FF, et al
    Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy.
    Inflamm Bowel Dis. 2018;24:380-386.
    PubMed     Abstract available


    December 2017
  608. BAKER DM, Lee MJ, Jones GL, Brown SR, et al
    The Informational Needs and Preferences of Patients Considering Surgery for Ulcerative Colitis: Results of a Qualitative Study.
    Inflamm Bowel Dis. 2017;24:179-190.
    PubMed     Abstract available


  609. VAN GENNEP S, de Boer NK, D'Haens GR, Lowenberg M, et al
    Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
    Inflamm Bowel Dis. 2017;24:67-77.
    PubMed     Abstract available


  610. GROSSBERG LB, Papamichael K, Feuerstein JD, Siegel CA, et al
    A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;24:191-197.
    PubMed     Abstract available


  611. KELSO M, Weideman RA, Cipher DJ, Feagins LA, et al
    Factors Associated With Length of Stay in Veterans With Inflammatory Bowel Disease Hospitalized for an Acute Flare.
    Inflamm Bowel Dis. 2017;24:5-11.
    PubMed     Abstract available


  612. VAJRAVELU RK, Osterman MT, Aberra FN, Roy JA, et al
    Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization.
    Inflamm Bowel Dis. 2017;24:217-226.
    PubMed     Abstract available


  613. AFZALI A, Ciorba MA, Schwartz DA, Sharaf M, et al
    Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned.
    Inflamm Bowel Dis. 2017;24:2-4.
    PubMed     Abstract available


  614. HUNDORFEAN G, Chiriac MT, Mihai S, Hartmann A, et al
    Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2017;24:35-44.
    PubMed     Abstract available


  615. DI RUSCIO M, Vernia F, Ciccone A, Frieri G, et al
    Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?
    Inflamm Bowel Dis. 2017;24:78-92.
    PubMed     Abstract available


  616. NETZ U, Carter J, Eichenberger MR, Feagins K, et al
    Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;24:159-165.
    PubMed     Abstract available


  617. MYKLEBUST-HANSEN T, Aamodt G, Haugen M, Brantsaeter AL, et al
    Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa).
    Inflamm Bowel Dis. 2017;24:12-24.
    PubMed     Abstract available


  618. MARCHIONI BEERY RM, Barnes EL, Nadkarni A, Korzenik JR, et al
    Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.
    Inflamm Bowel Dis. 2017;24:25-34.
    PubMed     Abstract available


  619. WALJEE AK, Lipson R, Wiitala WL, Zhang Y, et al
    Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning.
    Inflamm Bowel Dis. 2017;24:45-53.
    PubMed     Abstract available


  620. HYAMS JS, Chan D, Adedokun OJ, Padgett L, et al
    Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit.
    Inflamm Bowel Dis. 2017;23:2227-2237.
    PubMed     Abstract available


  621. BARNES EL, Kochar B, Long MD, Martin CF, et al
    Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.
    Inflamm Bowel Dis. 2017;23:2189-2196.
    PubMed     Abstract available


  622. YE Z, Zhou Y, Huang Y, Wang Y, et al
    Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China.
    Inflamm Bowel Dis. 2017;23:2154-2164.
    PubMed     Abstract available


  623. EL-MATARY W, Dykes DMH, Bauman L, Elkadri A, et al
    Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.
    Inflamm Bowel Dis. 2017;23:2104-2108.
    PubMed     Abstract available


  624. SELINGER CP, Lenti MV, Clark T, Rafferty H, et al
    Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:2083-2088.
    PubMed     Abstract available


  625. ARSENEAU KKO, Cominelli F
    Improving the Reproducibility and Quality of Reporting for Animal Studies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:2069-2071.
    PubMed    


    November 2017
  626. SHIBATA W, Sohara M, Wu R, Kobayashi K, et al
    Incidence and Outcomes of Central Venous Catheter-related Blood Stream Infection in Patients with Inflammatory Bowel Disease in Routine Clinical Practice Setting.
    Inflamm Bowel Dis. 2017;23:2042-2047.
    PubMed     Abstract available


  627. HOPKINS CWP
    Inflammatory Bowel Disease, the Hospital Anxiety and Depression Scale and Criterion Contamination.
    Inflamm Bowel Dis. 2017;23:E54.
    PubMed    


    October 2017
  628. ANDERSON A, Click B, Ramos-Rivers C, Cheng D, et al
    Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001251.
    PubMed     Abstract available


  629. GAWRONSKA A, Banasiuk M, Lachowicz D, Pituch H, et al
    Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001249.
    PubMed     Abstract available


  630. ZHANG W, Teng G, Wu T, Tian Y, et al
    Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001252.
    PubMed     Abstract available


  631. SIGURDSSON GV, Schmidt S, Mellstrom D, Ohlsson C, et al
    Bone Mass Development from Childhood into Young Adulthood in Patients with Childhood-onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 20. doi: 10.1097/MIB.0000000000001277.
    PubMed     Abstract available


  632. CONRAD MA, Dawany N, Sullivan KE, Devoto M, et al
    Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 11. doi: 10.1097/MIB.0000000000001280.
    PubMed     Abstract available


  633. PONTE A, Pinho R, Fernandes S, Rodrigues A, et al
    Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001275.
    PubMed     Abstract available


  634. ANANTHAKRISHNAN AN, Khalili H, Song M, Higuchi LM, et al
    Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001236.
    PubMed     Abstract available


  635. SO J, Tang W, Leung WK, Li M, et al
    Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001240.
    PubMed     Abstract available


  636. RIVIERE P, Poullenot F, Zerbib F, Laharie D, et al
    Quality of Sex Life in Patients with Inflammatory Bowel Disease: The Gastroenterologists' Perspective.
    Inflamm Bowel Dis. 2017;23:E51-E52.
    PubMed    


  637. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E50-E51.
    PubMed    


  638. GALLINGER ZR, Rumman A, Pivovarov K, Fortinsky KJ, et al
    Frequency and Variables Associated with Fasting Orders in Inpatients with Ulcerative Colitis: The Audit of Diet Orders-Ulcerative Colitis (ADORE-UC) Study.
    Inflamm Bowel Dis. 2017;23:1790-1795.
    PubMed     Abstract available


  639. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1702-1709.
    PubMed     Abstract available


  640. CROSS RK
    Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1689-1701.
    PubMed     Abstract available


  641. LIU X, Yu R, Zhu L, Hou X, et al
    Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:1741-1751.
    PubMed     Abstract available


    September 2017
  642. KRAWIEC P, Mroczkowska-Juchkiewicz A, Pac-Kozuchowska E
    Serum Hepcidin in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Sep 22. doi: 10.1097/MIB.0000000000001245.
    PubMed     Abstract available


  643. ROBLIN X, Boschetti G, Duru G, Williet N, et al
    Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.
    Inflamm Bowel Dis. 2017 Sep 22. doi: 10.1097/MIB.0000000000001223.
    PubMed     Abstract available


  644. PETERSEN BS, August D, Abt R, Alddafari M, et al
    Targeted Gene Panel Sequencing for Early-onset Inflammatory Bowel Disease and Chronic Diarrhea.
    Inflamm Bowel Dis. 2017 Sep 19. doi: 10.1097/MIB.0000000000001235.
    PubMed     Abstract available


  645. NGUYEN VQ, Jiang D, Hoffman SN, Guntaka S, et al
    Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2017 Sep 6. doi: 10.1097/MIB.0000000000001257.
    PubMed     Abstract available


  646. VANCAMELBEKE M, Vanuytsel T, Farre R, Verstockt S, et al
    Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Sep 6. doi: 10.1097/MIB.0000000000001246.
    PubMed     Abstract available


  647. PARK KT, Heida A, van Rheenen PF
    Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E47.
    PubMed    


  648. DAI C, Cao Q, Jiang M
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E46-E47.
    PubMed    


  649. PAPAMICHAEL K, Casteele NV, Ferrante M, Gils A, et al
    Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Inflamm Bowel Dis. 2017;23:1510-1515.
    PubMed     Abstract available


  650. TANG MS, Bowcutt R, Leung JM, Wolff MJ, et al
    Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.
    Inflamm Bowel Dis. 2017;23:1544-1554.
    PubMed     Abstract available


    August 2017
  651. ALLEGRETTI J, Eysenbach LM, El-Nachef N, Fischer M, et al
    The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001247.
    PubMed     Abstract available


  652. LIGHTNER AL, McKenna NP, Moncrief S, Pemberton JH, et al
    Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001248.
    PubMed     Abstract available


  653. KONIJETI GG, Kim N, Lewis JD, Groven S, et al
    Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001221.
    PubMed     Abstract available


  654. KAMMERLANDER H, Nielsen J, Knudsen T, Kjeldsen J, et al
    Anti-TNF-alpha Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001234.
    PubMed     Abstract available


  655. MUDIREDDY P, Scott F, Feathers A, Lichtenstein GR, et al
    Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001242.
    PubMed     Abstract available


  656. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 23. doi: 10.1097/MIB.0000000000001239.
    PubMed    


  657. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Aug 23. doi: 10.1097/MIB.0000000000001228.
    PubMed     Abstract available


  658. HYAMS JS, Kugathasan S, Dubinsky MC
    Combination Therapy in Pediatric Inflammatory Bowel Disease: Yes, No, Maybe.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001206.
    PubMed    


  659. CHRISTIAN KE, Jambaulikar GD, Hagan MN, Syed AM, et al
    Predictors of Early Readmission in Hospitalized Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001213.
    PubMed     Abstract available


  660. GOLD SL, Cohen-Mekelburg S, Schneider Y, Shen N, et al
    Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001189.
    PubMed     Abstract available


  661. BHANDARI S, Mohammed Abdul MK, Dhakal B, Kreuziger LB, et al
    Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001218.
    PubMed     Abstract available


  662. CHENG J, Hamilton Z, Smyth M, Barker C, et al
    Concomitant Therapy with Immunomodulator Enhances Infliximab Durability in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001212.
    PubMed     Abstract available


  663. LU Y, Zamora-Ros R, Chan S, Cross AJ, et al
    Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC).
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001108.
    PubMed     Abstract available


  664. LI SX, Thompson KD, Peterson T, Huneven S, et al
    Delivering High Value Inflammatory Bowel Disease Care Through Telemedicine Visits.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001210.
    PubMed     Abstract available


  665. BRAMUZZO M, Stocco G, Montico M, Arrigo S, et al
    Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001195.
    PubMed     Abstract available


  666. KLAG T, Mazurak N, Fantasia L, Schwille-Kiuntke J, et al
    High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001216.
    PubMed     Abstract available


  667. PARK KT, Heida A, van Rheenen PF
    Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001229.
    PubMed    


  668. DAI C, Cao Q, Jiang M
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001225.
    PubMed    


  669. PAPAMICHAEL K, Casteele NV, Ferrante M, Gils A, et al
    Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001231.
    PubMed     Abstract available


  670. ISAKOV O, Dotan I, Ben-Shachar S
    Machine Learning-Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 8. doi: 10.1097/MIB.0000000000001222.
    PubMed     Abstract available


  671. MARIN-JIMENEZ I, Gobbo Montoya M, Panadero A, Canas M, et al
    Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project.
    Inflamm Bowel Dis. 2017 Aug 3. doi: 10.1097/MIB.0000000000001205.
    PubMed     Abstract available


  672. PEPE J, Zawadynski S, Herrmann FR, Juillerat P, et al
    Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC).
    Inflamm Bowel Dis. 2017;23:1410-1417.
    PubMed     Abstract available


  673. JOLVING LR, Nielsen J, Beck-Nielsen SS, Nielsen RG, et al
    The Association Between Maternal Chronic Inflammatory Bowel Disease and Long-term Health Outcomes in Children-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2017;23:1440-1446.
    PubMed     Abstract available


  674. SUN C, Zhao Y, Gao X, Yuan Y, et al
    Cideb Deficiency Aggravates Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice by Exacerbating the Oxidative Burden in Colonic Mucosa.
    Inflamm Bowel Dis. 2017;23:1338-1347.
    PubMed     Abstract available


  675. AL-DARMAKI A, Hubbard J, Seow CH, Leung Y, et al
    Clinical Predictors of the Risk of Early Colectomy in Ulcerative Colitis: A Population-based Study.
    Inflamm Bowel Dis. 2017;23:1272-1277.
    PubMed     Abstract available


  676. TIAO DK, Chan W, Jeganathan J, Chan JT, et al
    Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1257-1261.
    PubMed     Abstract available


    July 2017
  677. BAKER DM, Marshall JH, Lee MJ, Jones GL, et al
    A Systematic Review of Internet Decision-Making Resources for Patients Considering Surgery for Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001198.
    PubMed     Abstract available


  678. COHN HM, Dave M, Loftus EV Jr
    Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001199.
    PubMed     Abstract available


  679. AGUAS PERIS M, Boso V, Navarro B, Marques-Minana MR, et al
    Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001182.
    PubMed     Abstract available


  680. MARTIN T, Smukalla SM, Kane S, Hudesman DP, et al
    Receptive Anal Intercourse in Patients with Inflammatory Bowel Disease: A Clinical Review.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001186.
    PubMed     Abstract available


  681. VOSKENS CJ, Fischer A, Roessner S, Lorenz C, et al
    Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001192.
    PubMed     Abstract available


  682. SYED S, Michalski ES, Tangpricha V, Chesdachai S, et al
    Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001178.
    PubMed     Abstract available


  683. SEVERS M, Mangen MJ, Fidder HH, van der Valk ME, et al
    Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001201.
    PubMed     Abstract available


  684. MATSUNO H, Kayama H, Nishimura J, Sekido Y, et al
    CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001204.
    PubMed     Abstract available


  685. STARK CM, Gorman GH, Nylund CM
    Association of Inflammatory Bowel Disease and Urolithiasis in Hospitalized Pediatric Patients.
    Inflamm Bowel Dis. 2017 Jul 10. doi: 10.1097/MIB.0000000000001188.
    PubMed     Abstract available


  686. ROBER N, Noss L, Goihl A, Reinhold D, et al
    Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 6. doi: 10.1097/MIB.0000000000001159.
    PubMed     Abstract available


  687. JANMOHAMED N, Steinhart AH
    Measuring Severity of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Low Concordance Between Patients and Male Gastroenterologists.
    Inflamm Bowel Dis. 2017;23:1168-1173.
    PubMed     Abstract available


  688. KHALILI H, de Silva PS, Ananthakrishnan AN, Lochhead P, et al
    Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1088-1095.
    PubMed     Abstract available


    June 2017
  689. TAXONERA C, Rodriguez C, Bertoletti F, Menchen L, et al
    Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 30. doi: 10.1097/MIB.0000000000001144.
    PubMed     Abstract available


  690. MA C, Lumb R, Walker EV, Foshaug RR, et al
    Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Jun 20. doi: 10.1097/MIB.0000000000001173.
    PubMed     Abstract available


  691. CARLSEN K, Houen G, Jakobsen C, Kallemose T, et al
    Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001170.
    PubMed     Abstract available


  692. MEIJER B, Seinen ML, van Egmond R, Bouma G, et al
    Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001168.
    PubMed     Abstract available


  693. EPPINGA H, Poortinga S, Thio HB, Nijsten TEC, et al
    Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001169.
    PubMed     Abstract available


  694. PEDERSEN M, Cromwell J, Nau P
    Sarcopenia is a Predictor of Surgical Morbidity in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 9. doi: 10.1097/MIB.0000000000001166.
    PubMed     Abstract available


  695. PEKOW J, Hutchison AL, Meckel K, Harrington K, et al
    miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
    Inflamm Bowel Dis. 2017 Jun 7. doi: 10.1097/MIB.0000000000001104.
    PubMed     Abstract available


  696. KOPYLOV U, Papamichael K, Katsanos K, Waterman M, et al
    Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001160.
    PubMed     Abstract available


  697. PATEL A, Panchal H, Dubinsky MC
    Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001157.
    PubMed     Abstract available


  698. AXELRAD JE, Joelson A, Nobel YR, Lawlor G, et al
    Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing.
    Inflamm Bowel Dis. 2017;23:1034-1039.
    PubMed     Abstract available


  699. GLASSNER K, Malaty HM, Abraham BP
    Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:998-1003.
    PubMed     Abstract available


  700. HEIDA A, Park KT, van Rheenen PF
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.
    Inflamm Bowel Dis. 2017;23:894-902.
    PubMed     Abstract available


  701. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:858-865.
    PubMed     Abstract available


  702. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:853-857.
    PubMed     Abstract available


  703. BERRY AC, Dholaria K, Czul-Gurdian F, Forster E, et al
    Relationship Between Patient Knowledge and Medication Adherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E39-E40.
    PubMed    


  704. HOPKINS CWP, Butt HS, Moulton CD
    Beyond Efficacy: The Acceptability of Antidepressant Treatment to Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E38.
    PubMed    


    May 2017
  705. DAN A, Boutros M, Nedjar H, Kopylov U, et al
    Cost of Ulcerative Colitis in Quebec, Canada: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2017 May 29. doi: 10.1097/MIB.0000000000001147.
    PubMed     Abstract available


  706. BUISSON A, Gonzalez F, Poullenot F, Nancey S, et al
    Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001140.
    PubMed     Abstract available


  707. LOPEZ RN, Evans HM, Appleton L, Bishop J, et al
    Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001138.
    PubMed     Abstract available


  708. FEAGINS LA, Waljee A, Hou JK, Gu P, et al
    Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001145.
    PubMed     Abstract available


  709. CHAO K, Wang X, Cao Q, Qian J, et al
    Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001148.
    PubMed     Abstract available


  710. BORREN NZ, Conway G, Tan W, Andrews E, et al
    Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001133.
    PubMed     Abstract available


  711. VALER P, Algaba A, Santos D, Fuentes ME, et al
    Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001081.
    PubMed     Abstract available


  712. FATTAHI MR, Malek-Hosseini SA, Sivandzadeh GR, Safarpour AR, et al
    Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001105.
    PubMed     Abstract available


  713. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001152.
    PubMed     Abstract available


  714. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001153.
    PubMed     Abstract available


  715. JULSGAARD M, Hvas CL, Gearry RB, Vestergaard T, et al
    Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001136.
    PubMed     Abstract available


  716. RESTALL GJ, Simms AM, Walker JR, Haviva C, et al
    Coping with Inflammatory Bowel Disease: Engaging with Information to Inform Health-Related Decision Making in Daily Life.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001141.
    PubMed     Abstract available


  717. KELLY OB, Donnell SO, Stempak JM, Steinhart AH, et al
    Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001126.
    PubMed     Abstract available


  718. JEGANATHAN J, Lee CH, Rahme A, Tiao DK, et al
    Pediatric-to-adult Transition and Medication Adherence in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001114.
    PubMed     Abstract available


  719. GUNALTAY S, Repsilber D, Helenius G, Nyhlin N, et al
    Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001127.
    PubMed     Abstract available


  720. YANG H, Zhou W, Lv H, Wu D, et al
    The Association Between CMV Viremia or Endoscopic Features and Histopathological Characteristics of CMV Colitis in Patients with Underlying Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:814-821.
    PubMed     Abstract available


  721. THORLACIUS-USSING G, Schnack Nielsen B, Andersen V, Holmstrom K, et al
    Expression and Localization of miR-21 and miR-126 in Mucosal Tissue from Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:739-752.
    PubMed     Abstract available


  722. BURKE KE, Haviland MJ, Hacker MR, Shainker SA, et al
    Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:721-726.
    PubMed     Abstract available


  723. FOULON A, Dupas JL, Sabbagh C, Chevreau J, et al
    Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017;23:712-720.
    PubMed     Abstract available


  724. NGUYEN GC, Murthy SK, Bressler B, Lam MCW, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017;23:695-701.
    PubMed     Abstract available


  725. ASSA A, Bronsky J, Kolho KL, Zarubova K, et al
    Anti-TNFalpha Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure.
    Inflamm Bowel Dis. 2017;23:791-797.
    PubMed     Abstract available


  726. DOTSON JL, Cho M, Bricker J, Kappelman MD, et al
    Race Differences in Initial Presentation, Early Treatment, and 1-year Outcomes of Pediatric Crohn's Disease: Results from the ImproveCareNow Network.
    Inflamm Bowel Dis. 2017;23:767-774.
    PubMed     Abstract available


  727. BROCHARD C, Siproudhis L, Leveque J, Grouin A, et al
    Factors Associated with Fecal Incontinence in Women of Childbearing Age with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:775-780.
    PubMed     Abstract available


  728. MA C, Fedorak RN, Kaplan GG, Dieleman LA, et al
    Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.
    Inflamm Bowel Dis. 2017;23:833-839.
    PubMed     Abstract available


  729. WILSON A, Tirona RG, Kim RB
    CYP3A4 Activity is Markedly Lower in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:804-813.
    PubMed     Abstract available


    April 2017
  730. VAVRICKA SR, Gubler M, Gantenbein C, Spoerri M, et al
    Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.
    Inflamm Bowel Dis. 2017 Apr 27. doi: 10.1097/MIB.0000000000001109.
    PubMed     Abstract available


  731. MAGNUSSON MK, Strid H, Isaksson S, Simren M, et al
    The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001130.
    PubMed     Abstract available


  732. JACOB V, Crawford C, Cohen-Mekelburg S, Viladomiu M, et al
    Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001132.
    PubMed     Abstract available


  733. BUHL S, Steenholdt C, Rasmussen M, Borghede MK, et al
    Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001117.
    PubMed     Abstract available


  734. BARNES EL, Kochar B, Long MD, Kappelman MD, et al
    Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.
    Inflamm Bowel Dis. 2017 Apr 19. doi: 10.1097/MIB.0000000000001121.
    PubMed     Abstract available


  735. LIGHTNER AL, Tse CS, Quinn K, Bergquist JR, et al
    Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001122.
    PubMed     Abstract available


  736. MARTINEZ B, Dailey F, Almario CV, Keller MS, et al
    Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease: Insights from a Large-scale Analysis of Social Media Platforms.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001110.
    PubMed     Abstract available


  737. ADAMS DW, Gurwara S, Silver HJ, Horst SN, et al
    Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001128.
    PubMed     Abstract available


  738. KOCHAR B, Long MD, Galanko J, Raffals LE, et al
    Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001115.
    PubMed     Abstract available


  739. VARNI JW, Shulman RJ, Self MM, Saeed SA, et al
    Patient Health Communication Mediating Effects Between Gastrointestinal Symptoms and Gastrointestinal Worry in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001077.
    PubMed     Abstract available


  740. BANASZKIEWICZ A, Gawronska A, Klincewicz B, Kofla-Dlubacz A, et al
    Immunogenicity of Pertussis Booster Vaccination in Children and Adolescents with Inflammatory Bowel Disease: A Controlled Study.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001076.
    PubMed     Abstract available


  741. NAVANEETHAN U, Edminister T, Zhu X, Kommaraju K, et al
    Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E17.
    PubMed    


  742. KHAN A, Chandler M, Borum ML
    Patients with Inflammatory Bowel Disease May Use Electronic Communication with Their Physicians More Frequently Than Those Without Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E16.
    PubMed    


  743. STOCCO G, Martelossi S, Arrigo S, Barabino A, et al
    Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:628-634.
    PubMed     Abstract available


  744. TANDON P, James P, Cordeiro E, Mallick R, et al
    Diagnostic Accuracy of Blood-Based Tests and Histopathology for Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2017;23:551-560.
    PubMed     Abstract available


  745. LAN N, Shen B
    Endoscopic Stricturotomy with Needle Knife in the Treatment of Strictures from Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:502-513.
    PubMed     Abstract available


  746. RUBIN DT, Dubinsky MC, Martino S, Hewett KA, et al
    Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits.
    Inflamm Bowel Dis. 2017;23:494-501.
    PubMed     Abstract available


  747. KISTANGARI G, Lopez R, Shen B
    Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study.
    Inflamm Bowel Dis. 2017;23:661-671.
    PubMed     Abstract available


  748. ZUNDLER S, Neurath MF
    Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:617-627.
    PubMed     Abstract available


  749. SHIYING W, Boyun S, Jianye Y, Wanjun Z, et al
    The Different Effects of VEGFA121 and VEGFA165 on Regulating Angiogenesis Depend on Phosphorylation Sites of VEGFR2.
    Inflamm Bowel Dis. 2017;23:603-616.
    PubMed     Abstract available


  750. SAEED MA, Ng GZ, Dabritz J, Wagner J, et al
    Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity.
    Inflamm Bowel Dis. 2017;23:593-602.
    PubMed     Abstract available


  751. GROSEN A, Kelsen J, Hvas CL, Bellaguarda E, et al
    The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure.
    Inflamm Bowel Dis. 2017;23:561-569.
    PubMed     Abstract available


  752. DE JONG M, van der Meulen-de Jong A, Romberg-Camps M, Degens J, et al
    Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach.
    Inflamm Bowel Dis. 2017;23:485-493.
    PubMed     Abstract available


  753. HRADSKY O, Soucek O, Maratova K, Matyskova J, et al
    Supplementation with 2000 IU of Cholecalciferol Is Associated with Improvement of Trabecular Bone Mineral Density and Muscle Power in Pediatric Patients with IBD.
    Inflamm Bowel Dis. 2017;23:514-523.
    PubMed     Abstract available


  754. CHAUDHRY NA, Riverso M, Grajo JR, Moser PP, et al
    A Fixed Stricture on Routine Cross-sectional Imaging Predicts Disease-Related Complications and Adverse Outcomes in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:641-649.
    PubMed     Abstract available


  755. SHAH ED, Farida JP, Siegel CA, Chong K, et al
    Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2017;23:570-577.
    PubMed     Abstract available


  756. BERNSTEIN CN, Burchill C, Targownik LE, Singh H, et al
    Maternal Infections That Would Warrant Antibiotic Use Antepartum or Peripartum Are Not a Risk Factor for the Development of IBD: A Population-Based Analysis.
    Inflamm Bowel Dis. 2017;23:635-640.
    PubMed     Abstract available


    March 2017
  757. NARULA N, Borges L, Steinhart AH, Colombel JF, et al
    Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001084.
    PubMed     Abstract available


  758. SUZUKI Y, Iida M, Ito H, Nishino H, et al
    2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001065.
    PubMed     Abstract available


  759. ANANTHAKRISHNAN AN, Donaldson T, Lasch K, Yajnik V, et al
    Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.
    Inflamm Bowel Dis. 2017 Mar 27. doi: 10.1097/MIB.0000000000001099.
    PubMed     Abstract available


  760. KAMMERLANDER H, Nielsen J, Kjeldsen J, Knudsen T, et al
    The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001102.
    PubMed     Abstract available


  761. HATA K, Ishii H, Anzai H, Ishihara S, et al
    Preoperative Extraintestinal Manifestations Associated with Chronic Pouchitis in Japanese Patients with Ulcerative Colitis After Ileal Pouch-anal Anastomosis: A Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001094.
    PubMed     Abstract available


  762. ZULLOW S, Fazelat A, Farraye FA
    Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001091.
    PubMed    


  763. EL-MATARY W
    Indicators of Quality of Care in Inflammatory Bowel Disease: Seeking the Right Path for Patients.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001069.
    PubMed    


  764. KHAN N, Patel D, Shah Y, Lichtenstein G, et al
    A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001080.
    PubMed     Abstract available


  765. NGUYEN GC, Murthy SK, Bressler B, Lam MC, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001068.
    PubMed     Abstract available


  766. NAVIGLIO S, Parentin F, Nider S, Rassu N, et al
    Ocular Involvement in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001079.
    PubMed     Abstract available


  767. ISHAK WW, Pan D, Steiner AJ, Feldman E, et al
    Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001060.
    PubMed     Abstract available


  768. ARORA Z, Mukewar S, Lopez R, Camino D, et al
    Etiopathogenesis of Nephrolithiasis in Ulcerative Colitis Patients with the Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001070.
    PubMed     Abstract available


  769. LIGHTNER AL, Mathis KL, Dozois EJ, Hahnsloser D, et al
    Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001061.
    PubMed     Abstract available


  770. KELSEN JR, Dawany N, Conrad M, Devoto M, et al
    Commentary on Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early-onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001028.
    PubMed    


  771. MACER BJ, Prady SL, Mikocka-Walus A
    Antidepressants in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001059.
    PubMed     Abstract available


  772. HUANG Z, Peng K, Li X, Zhao R, et al
    Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001058.
    PubMed     Abstract available


  773. SEXTON KA, Walker JR, Graff LA, Bernstein MT, et al
    Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:473-483.
    PubMed     Abstract available


  774. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:366-378.
    PubMed     Abstract available


  775. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017;23:357-365.
    PubMed     Abstract available


  776. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017;23:347-356.
    PubMed     Abstract available


  777. TARGOWNIK LE, Tennakoon A, Leung S, Lix LM, et al
    Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.
    Inflamm Bowel Dis. 2017;23:409-420.
    PubMed     Abstract available


  778. ZUNDLER S, Fischer A, Schillinger D, Binder MT, et al
    The alpha4beta1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo.
    Inflamm Bowel Dis. 2017;23:379-391.
    PubMed     Abstract available


  779. CARLSEN K, Haddad N, Gordon J, Phan BL, et al
    Self-efficacy and Resilience Are Useful Predictors of Transition Readiness Scores in Adolescents with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:341-346.
    PubMed     Abstract available


  780. SEINEN ML, van Asseldonk DP, de Boer NK, Bouma G, et al
    Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.
    Inflamm Bowel Dis. 2017;23:448-452.
    PubMed     Abstract available


  781. LOPETUSO LR, Jia R, Wang XM, Jia LG, et al
    Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis.
    Inflamm Bowel Dis. 2017;23:392-403.
    PubMed     Abstract available


  782. COWARD S, Kuenzig ME, Hazlewood G, Clement F, et al
    Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
    Inflamm Bowel Dis. 2017;23:461-472.
    PubMed     Abstract available


  783. GHOSH S, Louis E, Beaugerie L, Bossuyt P, et al
    Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:333-340.
    PubMed     Abstract available


  784. LU C, Gui X, Chen W, Fung T, et al
    Ultrasound Shear Wave Elastography and Contrast Enhancement: Effective Biomarkers in Crohn's Disease Strictures.
    Inflamm Bowel Dis. 2017;23:421-430.
    PubMed     Abstract available


  785. FAUBION WA, Dubinsky M, Ruemmele FM, Escher J, et al
    Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:453-460.
    PubMed     Abstract available


  786. HUANG Z, Chao K, Li M, Zhi M, et al
    Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Inflamm Bowel Dis. 2017;23:440-447.
    PubMed     Abstract available


    February 2017
  787. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001026.
    PubMed     Abstract available


  788. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001041.
    PubMed     Abstract available


  789. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001027.
    PubMed     Abstract available


  790. BRANDSE JF, Mould D, Smeekes O, Ashruf Y, et al
    A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Feb 10. doi: 10.1097/MIB.0000000000001043.
    PubMed     Abstract available


  791. KOPYLOV U, Ron Y, Avni-Biron I, Koslowsky B, et al
    Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.
    Inflamm Bowel Dis. 2017 Feb 7. doi: 10.1097/MIB.0000000000001039.
    PubMed     Abstract available


  792. RODRIGUEZ-PALACIOS A, Corridoni D, Di Stefano G, Di Martino L, et al
    O-014 Bacterial Sensor NOD2 Deletion Causes Th2-Inflammatory Bowel Disease Improvement Without Inducing Acute Metatranscriptomic Dysbiosis in Mice.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S5.
    PubMed     Abstract available


  793. HABERMAN Y, Ben-Shoshan M, Di-Segni A, Dexheimer P, et al
    O-009 Long ncRNA Landscape in the Ileum of Treatment Naive Early Onset Crohn Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3-S4.
    PubMed     Abstract available


  794. KIM ES, Jang BI, Kim KO, Kim EY, et al
    O-007 Impact of Education on School Nurses' Knowledge of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3.
    PubMed     Abstract available


  795. EL-MATARY W, Samson C, Crim A, Ali S, et al
    O-006 Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multi-Center North American Experience.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2-S3.
    PubMed     Abstract available


  796. SHAKHNOVICH V, Van Haandel L, Becker M, Funk R, et al
    O-005 Combination Therapy with Methotrexate Does Not Change Infliximab Pharmacokinetics in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2.
    PubMed     Abstract available


  797. DUPONT-LUCAS C, Grandjean-Blanchet C, Leduc B, Tripcovici M, et al
    Prevalence and Risk Factors for Symptoms of Methotrexate Intolerance in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:298-303.
    PubMed     Abstract available


  798. ALEXAKIS C, Saxena S, Chhaya V, Cecil E, et al
    Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Inflamm Bowel Dis. 2017 Feb 1. doi: 10.1097/MIB.0000000000001031.
    PubMed     Abstract available


  799. MAGRO F, Dias CC, Coelho R, Santos PM, et al
    Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling Outcomes.
    Inflamm Bowel Dis. 2017;23:289-297.
    PubMed     Abstract available


  800. ZAYYANI NR, Malaty HM, Graham DY
    Increasing Incidence of Crohn's Disease with Familial Clustering in the Kingdom of Bahrain: A 25-Year Population-based Study.
    Inflamm Bowel Dis. 2017;23:304-309.
    PubMed     Abstract available


  801. DIEDEREN K, de Ridder L, van Rheenen P, Wolters VM, et al
    Complications and Disease Recurrence After Primary Ileocecal Resection in Pediatric Crohn's Disease: A Multicenter Cohort Analysis.
    Inflamm Bowel Dis. 2017;23:272-282.
    PubMed     Abstract available


  802. VELONIAS G, Conway G, Andrews E, Garber JJ, et al
    Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:283-288.
    PubMed     Abstract available


  803. LI XH, Sun CH, Mao R, Huang SY, et al
    Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study.
    Inflamm Bowel Dis. 2017;23:244-253.
    PubMed     Abstract available


    January 2017
  804. RUAN J, Chen Y, Zhou Y
    Development and Validation of a Questionnaire to Assess the Quality of Life in Patients with Inflammatory Bowel Disease in Mainland China.
    Inflamm Bowel Dis. 2017 Jan 26. doi: 10.1097/MIB.0000000000001024.
    PubMed     Abstract available


  805. FIORINO G, Manetti N, Armuzzi A, Orlando A, et al
    The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000000995.
    PubMed     Abstract available


  806. KUCHARZIK T, Lemmnitz G, Abels C, Maaser C, et al
    Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001000.
    PubMed     Abstract available


  807. ABDALLA MI, Sandler RS, Kappelman MD, Martin CF, et al
    Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001017.
    PubMed     Abstract available


  808. QIN X
    Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001010.
    PubMed    


  809. KORELITZ BI, Shamah S
    The Ileitis of Ulcerative Colitis. Why Is It Not Crohn's Disease?
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001006.
    PubMed    


  810. SCHREINER P, Biedermann L, Rossel JB, Rogler G, et al
    Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001012.
    PubMed     Abstract available


  811. COENEN S, Weyts E, Jorissen C, De Munter P, et al
    Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001013.
    PubMed     Abstract available


  812. CHEN Y, Furuya-Kanamori L, Doi SA, Ananthakrishnan AN, et al
    Clostridium difficile Infection and Risk of Colectomy in Patients with Inflammatory Bowel Disease: A Bias-adjusted Meta-analysis.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000000998.
    PubMed     Abstract available


  813. LEWIS JD, Albenberg L, Lee D, Kratz M, et al
    The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001009.
    PubMed     Abstract available


  814. PICORARO J, Winberry G, Siegel CA, El-Matary W, et al
    Premedication Use Before Infliximab Administration: A Cross-sectional Analysis.
    Inflamm Bowel Dis. 2017;23:174-180.
    PubMed     Abstract available


  815. BETTENWORTH D, Gustavsson A, Atreja A, Lopez R, et al
    A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:133-142.
    PubMed     Abstract available


  816. ROBLIN X, Duru G, Williet N, Del Tedesco E, et al
    Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:126-132.
    PubMed     Abstract available


  817. GUMIDYALA AP, Plevinsky JM, Poulopoulos N, Kahn SA, et al
    What Teens Do Not Know Can Hurt Them: An Assessment of Disease Knowledge in Adolescents and Young Adults with IBD.
    Inflamm Bowel Dis. 2017;23:89-96.
    PubMed     Abstract available


  818. LIE MR, Kreijne JE, van der Woude CJ
    Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:75-81.
    PubMed     Abstract available


  819. COELHO R, Ribeiro H, Maconi G
    Bowel Thickening in Crohn's Disease: Fibrosis or Inflammation? Diagnostic Ultrasound Imaging Tools.
    Inflamm Bowel Dis. 2017;23:23-34.
    PubMed     Abstract available


  820. YARUR AJ, Quintero MA, Jain A, Czul F, et al
    Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:158-164.
    PubMed     Abstract available


  821. SANDS BE, Sandborn WJ, Van Assche G, Lukas M, et al
    Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy.
    Inflamm Bowel Dis. 2017;23:97-106.
    PubMed     Abstract available


  822. RISPO A, Imperatore N, Testa A, Mainenti P, et al
    Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index.
    Inflamm Bowel Dis. 2017;23:143-151.
    PubMed     Abstract available


  823. SAKURAI T, Kashida H, Komeda Y, Nagai T, et al
    Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer.
    Inflamm Bowel Dis. 2017;23:57-65.
    PubMed     Abstract available


  824. RAO BB, Click BH, Koutroubakis IE, Ramos Rivers C, et al
    The Cost of Crohn's Disease: Varied Health Care Expenditure Patterns Across Distinct Disease Trajectories.
    Inflamm Bowel Dis. 2017;23:107-115.
    PubMed     Abstract available


  825. VAN DER SLOOT KW, Joshi AD, Bellavance DR, Gilpin KK, et al
    Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:82-88.
    PubMed     Abstract available


  826. HOU JK, Gasche C, Drazin NZ, Weaver SA, et al
    Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:35-43.
    PubMed     Abstract available


  827. HERFARTH HH, Jackson S, Schliebe BG, Martin C, et al
    Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.
    Inflamm Bowel Dis. 2017;23:14-22.
    PubMed     Abstract available


    December 2016
  828. NGUYEN GC, Bernstein CN, Benchimol EI
    Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000993.
    PubMed     Abstract available


  829. RUBIN DT, Feld LD, Goeppinger SR, Margolese J, et al
    The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000994.
    PubMed     Abstract available


  830. HOU JK, Kramer JR, Richardson P, Sansgiry S, et al
    Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000001003.
    PubMed     Abstract available


  831. FRIEDMAN S, Larsen PV, Fedder J, Norgard BM, et al
    The Efficacy of Assisted Reproduction in Women with Inflammatory Bowel Disease and the Impact of Surgery-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000996.
    PubMed     Abstract available


  832. SIVA S, Rubin DT, Gulotta G, Wroblewski K, et al
    Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  833. TAHARA T, Hirata I, Nakano N, Nagasaka M, et al
    Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  834. GRACIE DJ, Ford AC
    Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation?
    Inflamm Bowel Dis. 2016.
    PubMed    


  835. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016;22:2794-2801.
    PubMed     Abstract available


    November 2016
  836. CUI DJ, Yang XL, Hu M, Yang LC, et al
    Effects of Preoperative Methotrexate on Complications After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed    


  837. ISHIKAWA D, Sasaki T, Osada T, Kuwahara-Arai K, et al
    Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  838. ROBINSON AM, Gondalia SV, Karpe AV, Eri R, et al
    Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  839. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  840. TAKESHITA K, Mizuno S, Mikami Y, Sujino T, et al
    A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  841. CALDERA F, Hayney MS
    Barriers to Administration of Herpes Zoster Immunization in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E44.
    PubMed    


  842. MOTTET C, Schoepfer AM, Juillerat P, Cosnes J, et al
    Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2733-2747.
    PubMed     Abstract available


  843. HASHASH JG, Sigal R, Wein-Levy P, Szigethy EM, et al
    Inflammatory Bowel Disease (IBD) Connect: A Novel Volunteer Program for Hospitalized Patients with IBD and Their Families.
    Inflamm Bowel Dis. 2016;22:2748-2753.
    PubMed     Abstract available


  844. GIANOTTI RJ, Moss AC
    The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2704-2710.
    PubMed     Abstract available


  845. REICH J, Guo L, Hall J, Tran A, et al
    A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2678-2687.
    PubMed     Abstract available


  846. COLLIJ V, Festen EA, Alberts R, Weersma RK, et al
    Drug Repositioning in Inflammatory Bowel Disease Based on Genetic Information.
    Inflamm Bowel Dis. 2016;22:2562-2570.
    PubMed     Abstract available


  847. TEW GA, Jones K, Mikocka-Walus A
    Physical Activity Habits, Limitations, and Predictors in People with Inflammatory Bowel Disease: A Large Cross-sectional Online Survey.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


    October 2016
  848. CHOY MC, Visvanathan K, De Cruz P
    An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  849. BARNES EL, Burakoff R
    New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  850. PALONE F, Vitali R, Cucchiara S, Mennini M, et al
    Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


    September 2016
  851. CHEN SW, Wang PY, Liu YC, Sun L, et al
    Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  852. CANEPARO V, Pastorelli L, Pisani LF, Bruni B, et al
    Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  853. JONEFJALL B, Ohman L, Simren M, Strid H, et al
    IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  854. QIN X
    Perinuclear Antineutrophil Cytoplasmic Antibody with a Large Portion Being Anti-beta-Glucuronidase, May Have Played a Causative Role in the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed    


    May 2016
  855. DEGRUTTOLA AK, Low D, Mizoguchi A, Mizoguchi E, et al
    Current Understanding of Dysbiosis in Disease in Human and Animal Models.
    Inflamm Bowel Dis. 2016;22:1137-50.
    PubMed     Abstract available


  856. DONEGAN A, Boyle B, Crandall W, Dotson JL, et al
    Connecting Families: A Pediatric IBD Center's Development and Implementation of a Volunteer Parent Mentor Program.
    Inflamm Bowel Dis. 2016;22:1151-6.
    PubMed     Abstract available


  857. GREENUP AJ, Bressler B, Rosenfeld G
    Medical Imaging in Small Bowel Crohn's Disease-Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound: "Which One Is the Best for What?".
    Inflamm Bowel Dis. 2016;22:1246-61.
    PubMed     Abstract available


  858. GANZ ML, Sugarman R, Wang R, Hansen BB, et al
    The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.
    Inflamm Bowel Dis. 2016;22:1032-41.
    PubMed     Abstract available


  859. CALABRESE E, Maaser C, Zorzi F, Kannengiesser K, et al
    Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts.
    Inflamm Bowel Dis. 2016;22:1168-83.
    PubMed     Abstract available


  860. SEHGAL P, Colombel JF, Narula N
    Adverse Events During Anti-TNFalpha Therapies in IBD (Excluding Infections and Malignancies): When to Stop, Continue, or Switch Therapies.
    Inflamm Bowel Dis. 2016;22:1239-45.
    PubMed     Abstract available


  861. SAAD AM, Czul F, Sakuraba A, Rubin DT, et al
    Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1027-31.
    PubMed     Abstract available


  862. FLASAR MH, Chao J, Ozbay AB, Skup M, et al
    Biological and Immunomodulator Use in Crohn's Disease in a Medicaid Population.
    Inflamm Bowel Dis. 2016;22:1056-64.
    PubMed     Abstract available


  863. CHACHU KA, Osterman MT
    How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD.
    Inflamm Bowel Dis. 2016;22:1262-74.
    PubMed     Abstract available


  864. HAYASHI R, Tsuchiya K, Fukushima K, Horita N, et al
    Reduced Human alpha-defensin 6 in Noninflamed Jejunal Tissue of Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1119-28.
    PubMed     Abstract available


  865. INOKUCHI T, Kato J, Hiraoka S, Takashima S, et al
    Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1078-85.
    PubMed     Abstract available


  866. CHEN ML, Sundrud MS
    Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:1157-67.
    PubMed     Abstract available


  867. GALE G, Sigurdsson GV, Ostman S, Malmborg P, et al
    Does Crohn's Disease with Concomitant Orofacial Granulomatosis Represent a Distinctive Disease Subtype?
    Inflamm Bowel Dis. 2016;22:1071-7.
    PubMed     Abstract available


  868. LIMKETKAI BN, Parian AM, Shah ND, Colombel JF, et al
    Short Bowel Syndrome and Intestinal Failure in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1209-18.
    PubMed     Abstract available


  869. MURAWSKA N, Fabisiak A, Fichna J
    Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment.
    Inflamm Bowel Dis. 2016;22:1198-208.
    PubMed     Abstract available


  870. WRIGHT EK, Kamm MA, De Cruz P, Hamilton AL, et al
    Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1086-94.
    PubMed     Abstract available


    April 2016
  871. BUCHNER AM, Lichtenstein GR
    How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.
    Inflamm Bowel Dis. 2016;22:1010-9.
    PubMed     Abstract available


  872. GILS A, Van Stappen T, Dreesen E, Storme R, et al
    Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples.
    Inflamm Bowel Dis. 2016;22:969-75.
    PubMed     Abstract available


  873. DUBINSKY MC, Rosh J, Faubion WA Jr, Kierkus J, et al
    Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:886-93.
    PubMed     Abstract available


  874. KAUR M, Panikkath D, Yan X, Liu Z, et al
    Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway.
    Inflamm Bowel Dis. 2016;22:862-9.
    PubMed     Abstract available


  875. VERGARA M, Sicilia B, Prieto L, Casellas F, et al
    Development and Validation of the Short Crohn's Disease Work Disability Questionnaire.
    Inflamm Bowel Dis. 2016;22:955-62.
    PubMed     Abstract available


  876. JUNG ES, Cheon JH, Lee JH, Park SJ, et al
    HLA-C*01 is a Risk Factor for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:796-806.
    PubMed     Abstract available


  877. MA C, Beilman CL, Huang VW, Fedorak DK, et al
    Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2016;22:870-9.
    PubMed     Abstract available


    March 2016
  878. MIKOCKA-WALUS A, Knowles SR, Keefer L, Graff L, et al
    Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:752-62.
    PubMed     Abstract available


  879. WITTEN J, Siles R, Shen B, Yao Q, et al
    Triple Disease Combination: Familial Mediterranean Fever, Crohn's Disease, and Chronic Idiopathic Urticaria with Angioedema.
    Inflamm Bowel Dis. 2016;22:E12-3.
    PubMed    


  880. KRUGLIAK CLEVELAND N, Colman RJ, Rodriquez D, Hirsch A, et al
    Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
    Inflamm Bowel Dis. 2016;22:631-7.
    PubMed     Abstract available


  881. KJELDSEN J, Nielsen J, Larsen MD, Qvist N, et al
    Postoperative Use of Anti-TNF-alpha Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016;22:599-606.
    PubMed     Abstract available


  882. ROY A, Lichtiger S
    Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:648-53.
    PubMed     Abstract available


  883. CARRIERE J, Bretin A, Darfeuille-Michaud A, Barnich N, et al
    Exosomes Released from Cells Infected with Crohn's Disease-associated Adherent-Invasive Escherichia coli Activate Host Innate Immune Responses and Enhance Bacterial Intracellular Replication.
    Inflamm Bowel Dis. 2016;22:516-28.
    PubMed     Abstract available


  884. CLEYNEN I, Konings P, Robberecht C, Laukens D, et al
    Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:505-15.
    PubMed     Abstract available


  885. CHOI SH, Kim KW, Lee JY, Kim KJ, et al
    Diffusion-weighted Magnetic Resonance Enterography for Evaluating Bowel Inflammation in Crohn's Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2016;22:669-79.
    PubMed     Abstract available


  886. SAMAAN MA, de Jong D, Sahami S, Morgan S, et al
    Incidence and Severity of Prepouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory Pouchitis?
    Inflamm Bowel Dis. 2016;22:662-8.
    PubMed     Abstract available


    February 2016
  887. MONIF GR
    Translation of Hypothesis to Therapy in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:E8-9.
    PubMed    


  888. WALTER JG, Kahn SA, Noe JD, Schurman JV, et al
    Feeling Fine: Anxiety and Depressive Symptoms in Youth with Established IBD.
    Inflamm Bowel Dis. 2016;22:402-8.
    PubMed     Abstract available


  889. MIKOCKA-WALUS A, Andrews JM, Bampton P
    Cognitive Behavioral Therapy for IBD.
    Inflamm Bowel Dis. 2016;22:E5-6.
    PubMed    


  890. SORRENTINO D
    Preclinical and Undiagnosed Crohn's Disease: The Submerged Iceberg.
    Inflamm Bowel Dis. 2016;22:476-86.
    PubMed     Abstract available


  891. HARRIS KA, Horst S, Gadani A, Nohl A, et al
    Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab.
    Inflamm Bowel Dis. 2016;22:397-401.
    PubMed     Abstract available


  892. GRAY WN, Maddux MH
    Current Transition Practices in Pediatric IBD: Findings from a National Survey of Pediatric Providers.
    Inflamm Bowel Dis. 2016;22:372-9.
    PubMed     Abstract available


  893. DUCHATELLIER CF, Kumar R, Krupoves A, Braegger C, et al
    Steroid Administration and Growth Impairment in Children with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:355-63.
    PubMed     Abstract available


  894. NAFTALI T, Reshef L, Kovacs A, Porat R, et al
    Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:293-302.
    PubMed     Abstract available


  895. OCHOA-CORTES F, Turco F, Linan-Rico A, Soghomonyan S, et al
    Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:433-49.
    PubMed     Abstract available


  896. SUNADA K, Shinozaki S, Nagayama M, Yano T, et al
    Long-term Outcomes in Patients with Small Intestinal Strictures Secondary to Crohn's Disease After Double-balloon Endoscopy-assisted Balloon Dilation.
    Inflamm Bowel Dis. 2016;22:380-6.
    PubMed     Abstract available


  897. MENYS A, Makanyanga J, Plumb A, Bhatnagar G, et al
    Aberrant Motility in Unaffected Small Bowel is Linked to Inflammatory Burden and Patient Symptoms in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:424-32.
    PubMed     Abstract available


  898. GAWRON LM, Sanders J, Steele KP, Flynn AD, et al
    Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:459-64.
    PubMed     Abstract available


  899. GOLAN D, Gross B, Miller A, Klil-Drori S, et al
    Cognitive Function of Patients with Crohn's Disease is Associated with Intestinal Disease Activity.
    Inflamm Bowel Dis. 2016;22:364-71.
    PubMed     Abstract available


    January 2016
  900. BETTENWORTH D, Rieder F
    Reversibility of Stricturing Crohn's Disease-Fact or Fiction?
    Inflamm Bowel Dis. 2016;22:241-7.
    PubMed     Abstract available


  901. VAZEILLE E, Chassaing B, Buisson A, Dubois A, et al
    GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.
    Inflamm Bowel Dis. 2016;22:68-81.
    PubMed     Abstract available


  902. HERFARTH HH, Kappelman MD, Long MD, Isaacs KL, et al
    Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:224-33.
    PubMed     Abstract available


  903. MCCONNELL RA, Mahadevan U
    Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
    Inflamm Bowel Dis. 2016;22:213-23.
    PubMed     Abstract available


  904. REICH KM, Fedorak RN, Madsen K, Kroeker KI, et al
    Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:92-9.
    PubMed     Abstract available


  905. MANCINA RM, Spagnuolo R, Milano M, Brogneri S, et al
    PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.
    Inflamm Bowel Dis. 2016;22:134-40.
    PubMed     Abstract available


  906. ZUO L, Li Y, Zhu W, Shen B, et al
    Mesenteric Adipocyte Dysfunction in Crohn's Disease is Associated with Hypoxia.
    Inflamm Bowel Dis. 2016;22:114-26.
    PubMed     Abstract available


    October 2015
  907. PUTIGNANI L, Del Chierico F, Vernocchi P, Cicala M, et al
    Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Inflamm Bowel Dis. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: